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Foreword
This is the Neonatal Therapeutic Hypothermia re-
port for 2019. The working partnership between 
the National Perinatal Epidemiology Centre, the 
National Women and Infant Health Programme 
and the National Clinical Programme for Paedi-
atrics and Neonatology continues to be produc-
tive. This year marks the third published report. 
The Therapeutic Hypothermia (TH) steering 
committee continues to oversee the governance 
of this project and its members remain commit-
ted to the building of a national register for TH 
cases in Republic of Ireland.
The electronic register was launched in early 
March 2020 and this system was utilised for the 
2019 TH data collection. The data was collect-
ed and verified by the National TH Co-ordinator 
who visited the maternity units. The findings are 
accurate and applicable to clinical practice. This 
year, for the first time, data was collected on 
the Bayley Scales of Infant and Toddler Devel-
opment, 3rd edition (BSID-III) assessment of the 
infants. This developmental assessment is un-
dertaken when the infant is aged two years. This 
assessment provides information on the longer-
term outcome of the infant cohort.
The National Neonatal Encephalopathy Action 
Group (NNEAG) which is a collaborative initiative 
between the National Women and Infants Health 
Programme (NWIHP), State Claims Agency and 
Department of Health has been established. The 
remit of the NNEAG is to reduce avoidable cas-
es of Neonatal Encephalopathy (NE) through 
the identification of risk factors and the devel-
opment and implementation of initiatives in the 
maternity services that will reduce these risks. 
While acknowledging that many of these ad-
verse outcomes are not preventable, in light of 
current evidence, the ambition must be to elim-
inate cases which may be preventable. The Roy-
al College of Obstetrics and Gynaecology ‘Each 
Baby Counts’ has set a target to reduce NE by 
50%, while it is ambitious this country should 
have a similar goal.1
This year, 2020, has been difficult for the Health 
Service Executive and its staff due to COVID-19. 
The impact on the way services are delivered has 
been challenged. We wish to acknowledge the 
hard work and unfaltering dedication staffs have 
shown in the maternity services to ensure both 
mothers and infants continue to receive high 
quality care. All maternity sites have again been 
unwavering in their support for the project and 
their support enables it to drive forward.
With thanks, we look forward to once again 
working with all stakeholders in 2021 and build-
ing upon the knowledge achieved to date. 
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This Report provides details on the 72 infants in Ireland 
with Neonatal Encephalopathy (NE) who required Ther-
apeutic Hypothermia (TH) in 2019. Findings on all 281 
cases in the four-year period 2016-2019 are also pro-
vided. This constitutes a large national cohort recorded 
for a period during which almost 250,000 infants were 
born in Ireland. The incidence of TH was 1.2 per 1,000 
births in 2019 and the rate of TH for the period 2016-
2019 was 1.1 per 1,000 births. The rate year-on-year has 
remained relatively constant with minor fluctuations 
suggesting that the underlying factors in its aetiology 
and causation are consistent and repetitive.
NE is a disorder consisting of abnormal neurological 
behaviour and seizures present in infants from birth. 
Most of the cases of NE are due to the lack of oxygen to 
the infant either before or during labour. It is worth re-
flecting that up to the late ‘90s there was no treatment 
for these infants. Following scientific advances and well 
conducted Randomized Control Trials (RCTs) a treat-
ment has been available since 20092–4. This treatment 
is induced Neonatal Therapeutic Hypothermia. Infants 
undergo total body cooling at 33-34°C for a period of 
72 hours, commencing within six hours of birth. TH is 
now considered the standard of care for infants suffer-
ing from moderate and severe NE. All the cases of NE 
reported in this document received TH. 
The purpose of the National Neonatal TH Development 
Project is twofold. First, it is an analysis of the epide-
miology, antecedent obstetric, and intrapartum factors 
leading to NE. Secondly, it is a documentation of the 
immediate and subsequent neonatal management and 
outcome of the infants suffering from NE. 
In line with international evidence, this report shows 
that infants born to first-time mothers are at increased 
risk of needing TH. Based on data for 2016-2019, the 
observed risk for these infants was 1.76 per 1,000 births, 
more than twice the risk of 0.75 per 1,000 observed for 
infants born to multiparous mothers. In mothers with 
a BMI >30, the TH rate was 1.5 per 1,000 maternities, 
compared with 0.9 per 1,000 maternities in those with 
a BMI <30. Although this finding is amenable to cor-
rection, it remains challenging. Mothers from Asian and 
Black ethnic groups accounted for 10% of the mothers 
whose infants received TH in 2016-2019. This is twice 
the 5% that mothers from these ethnic groups account-
ed for in the female population aged 15-49 in 2016, and 
so they may be a vulnerable or at risk group. However, 
the lack of national maternity data on ethnicity limits 
our ability to assess their risk. 
There are two other factors that are noteworthy. First, 
maternal age does not appear to be associated with the 
need for TH intervention. Given that most reproductive 
outcomes are negatively impacted by increasing mater-
nal age, this finding is interesting and reassuring. The 
second point, is that twins do not feature as a recurrent 
theme in this cohort of infants.
The finding that twins are not over-represented sug-
gests that once recognised as a risk the obstetric man-
agement is satisfactory in this cohort of mothers.
Cardiotocography (CTG) is a tool used by midwives 
and obstetricians to record the fetal heart rate and con-
tractions and can assist with detecting signs of fetal 
compromise. This year a blinded review of the intrapar-
tum CTGs from one hour pre-delivery were reviewed by 
a small panel of experts (for methodology see pg 12). 
A number of normal control CTGs were also included. 
Not all infants who required TH in 2019 had ongoing fe-
tal monitoring. As such, 59 of the 72 infants had a CTG 
available for review by the group. For each case, the 
CTG for the final 1 hour before delivery was reviewed. 
The review panel categorised 42 CTGs as pathological, 
12 CTGs were categorised as suspicious, and 5 CTGs 
were deemed to be normal. The subjective nature of 
CTG interpretation compounds the necessity to ensure 
a ‘second eyes’ approach and the need to make clinical 
decisions based on complete clinical information, par-
ticularly progress in labour.
In 2019, 13 mothers had a caesarean section prior to 
labour. In 12 of these cases, fetal compromise such as 
placental abruption and decreased fetal movements 
was identified. Four of the mothers who were classified 
as never-in-labour had presented themselves to hos-
pital querying that spontaneous onset of labour had 
commenced. The difficulty in diagnosing labour is an 
emerging issue and has been noted in other reports5.
This year, for the first time, the report details times 
related to the care and labour of mothers with Spon-
taneous Onset of Labour (SOL) though documented 
times were unavailable for 1 in 4 mothers. For those 
with data available, half of the mothers had their labour 
diagnosed within approximately one hour of admission 
to hospital. Twenty eight percent of mothers who pre-
sented themselves to hospital with a possible diagnosis 
of SOL, were not admitted to the labour ward for great-
er than 5 hours. Over the four year period detailed in 
this aggregate report, only 4 infants of the combined 
total of 281 infants who required TH were delivered by 
elective section. This strongly suggests that labour and 
its management are important determinants of an out-
come that requires TH intervention. 
In 2019, 26 of the mothers whose infants developed NE 
requiring TH had their labour induced, 17 of these 26 
mothers were nulliparous. Only four of these mothers 
were noted to have a documented favourable cervix, 
and in 14 cases the Bishop score was less than six. Sen-
ior involvement and continual risk assessment in this 
cohort of mothers is advocated. 
Executive Summary
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Shoulder dystocia was associated with the delivery of 
12.8% of the 281 infants who received TH in 2016-2019. 
This is 19 times more common than recorded for all 
mothers who gave birth in hospital during 2016-2019, 
according to Hospital In-Patient Enquiry data. Com-
pared to the other TH cases, those affected by shoul-
der dystocia more often involved first-time mothers, 
mothers who were overweight/obese, had an induction 
of labour and those with higher birthweight infants.
As noted in previous years, being a small for date’s in-
fant is associated with the need for TH intervention. 
There is an excess number of small-for-dates infants in 
the TH group (P<0.001). The rate of birthweight <10th 
centile in the infants who underwent TH in the four year 
timeframe 2016-2019, is 174 per 1,000 compared with 
100 per 1,000 in the general population. 
Many infants with NE are severely compromised at 
birth. It is a condition with a high morbidity and a high 
mortality. In 2019, 15 of the infants with NE requiring 
TH died. Over the four years of data collection, there 
have been 39 deaths representing a 14% mortality rate 
amongst the cohort. Not all cases of NE are avoidable 
but some may be. Only through reflective and critical 
evaluation can we learn how different, but reasonable, 
clinical management could alter the outcome. This year 
we are including a suggested template for use when 
reviewing cases of NE requiring TH (see Appendix A). 
This template has been designed to reflect the sentinel 
events and the recurring themes which have emerged 
in the aggregate NE cases requiring TH over the four 
years from 2016-2019. 
Over the four year period 2016-2019, there was a mod-
erate non-significant preponderance of male infants 
with NE requiring TH with 158 male infants compared 
to 123 female infants. The need for intensive neona-
tal resuscitation in 2019 was frequent, 60% of infants 
required endotracheal intubation and 35% required 
cardiac compressions. In 2019, 19% of infants detailed 
in this report had no heart beat at 1 minute. In 2019, 
80% of infants had a very low APGAR score (0-3) at 
1 minute. Over the 4 years 2016-2019, 51 infants had 
no heart rate at birth. All these infants required exten-
sive resuscitation highlighting the importance of hav-
ing suitably trained personnel with up-to-date neonatal 
resuscitation programme (NRP) certification at all ma-
ternity sites, who are capable of performing neonatal 
resuscitation. A National Neonatal Resuscitation Pro-
gramme (NRP) co-ordinator took up post in October 
2020. The NRP Co-ordinator will establish the national 
governance for the provision of NRP training and its 
implementation. 
In 2019, 46 (64%)of infants requiring TH were born in 
a maternity unit with a tertiary Neonatal Intensive Care 
Unit (NICU) and the other 26 (36%) of infants were 
transferred from a peripheral unit to the tertiary centre 
for on-going neonatal care and assessment. In 2019, all 
26 outborn infants were initially passively cooled. In 80% 
of these cases a referral call was made to the tertiary 
centre within two hours of the birth. From the outborn 
group 84% were transferred by the National Neonatal 
Transport Programme (NNTP), and the other cases by 
the referring hospital’s team. TH was continued during 
transport in all cases where infants were transferred to a 
tertiary centre. The vast majority of infants (90%), both 
inborn and outborn, achieved optimal core temperature 
33-34°C within six hours of birth.
In 38 cases a venous blood gas was drawn for the in-
itial infant blood gas, 12 gases were capillary and 20 
gases were arterial. Venous blood samples are not the 
gold standard for infant blood gases especially in cas-
es where a baby is suspected of requiring TH. In cases 
where an infant is compromised and suspected of re-
quiring TH clinicians should aim to carry out a capillary 
or arterial blood gas as the first infant gas as both of 
these samples give more meaningful information with 
regard to the infants condition. 
It is strongly recommended that the decision to in-
stitute TH for an infant with suspected NE should be 
based on the Cooling Candidacy Checklist (see Appen-
dix B). The criteria includes; the history of a sentinel 
event, low APGAR score, low cord pH, base excess ≥ 
16mmol/l, continued need for positive pressure ventila-
tion or intubation beyond 10 minutes, and an abnormal 
neurological examination. In 2019, the checklist was 
used in 67% of cases. It is urged that the Cooling Can-
didacy Checklist is used every time TH is being consid-
ered for an infant to help ensure the consistent applica-
tion of TH treatment.
The Sarnat score is the optimal way of accurately cate-
gorising an infant’s grade of encephalopathy. The score 
provides a record of the infant’s neurological impair-
ment. The score is also recommended by the updated 
British Association of Perinatal Medicine (BAPM) guide-
lines ‘Therapeutic Hypothermia for Neonatal Encepha-
lopathy6. In 2019, the Sarnat score was performed on 
65% of infants on day 1, 42% on day 2, and 40% on day 3 
of cooling. As a consequence 31% of cases had no grade 
of encephalopathy assigned at the time of discharge. 
Where an assessment was made the grading of enceph-
alopathy was severe (13%), moderate (42%), mild to 
moderate (7%) or mild (7%). A local Quality Initiative 
(QI) Project in a tertiary maternity hospital demonstrat-
ed an improvement in documented neurological assess-
ment for 2019 TH cases7. A national roll-out of this QI 
is warranted to achieve improvements with regard to 
documentation of neurological assessments for infants 
undergoing TH. Teaching score cards have been made 
available and distributed to the four tertiary sites offer-
ing TH (see Appendix C).
The Amplitude Integrated Electroencephalogram 
(aEEG) is the other important tool in the assessment 
of the infant’s neurological status. Daily documentation 
should be entered while the infant is undergoing TH8. 
In 2019, the aEEG findings were not recorded in 48% 
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of cases on day 1, 62% on day 2, and 72% on day 3 of 
TH. A teaching tool is available on the RCPI website. 
In 2019, one third of infants had seizures over the first 
three days of life. This represents a reduction in the sei-
zure burden compared with the pre-cooling era when 
seizures were very common.
Among the various laboratory investigations undertak-
en for each infant in 2019, the one to pay attention to 
is the serum sodium as 65% of the TH infants a serum 
sodium less than 131mmol/l. Conceivably a low sodium 
value in this setting reflects a hypoxic brain and kidney 
injury. 
Persistent nasogastric feeding beyond 72 hours and 
particularly at discharge is indicative of persistent neu-
rological impairment. Almost 30% of infants needed 
nasogastric feeds beyond 72 hours and 10% were still 
on tube feeds on day of discharge home.
In all of TH cases in 2019 infants were administered an-
tibiotics. While a blood culture was performed in every 
case, only 20% subsequently had a lumbar puncture 
undertaken. A micro-array test was performed in 5% 
of cases. There should be a standardised approach to 
these investigations for all infants undergoing cooling.
A brain MRI scan is routinely undertaken in all infants 
with NE treated with TH. It is an important predictor of 
both short-term and long-term neurological and devel-
opmental outcome. It is generally advised to undertake 
the scan in the first 5-10 days of life. In the 2019, 90% had 
an MRI by day 10, and the other 10% had one between 
days 10-15. For the purposes of this report the infants’ 
MRI scans have been assessed using the Barkovich scor-
ing system. Of the available MRI brain reports from the 
4 year period 2016-2019, 114 (40%) were abnormal. The 
most common abnormality encountered was ischaemic 
changes in the cerebral cortex. The most severe injuries 
were those involving the thalamus, lentiform nucleus, 
and peri-rolandic cortex.
The relationship between NE and placental pathology 
is complex. TH may rescue infants from some of the 
consequences of placental disease The current un-
derstanding of most clinicians is that pre-existing pla-
cental pathology may compromise the fetal ability to 
withstand the stress of labour, and in some cases may 
directly cause damage to the fetal brain and other or-
gans. One of the aims of the project is get a better pic-
ture about the interaction between placenta patholo-
gy and birth asphyxia. Perinatal pathologists point out 
that the placenta is the ‘black box’ of the pregnancy. 
The first challenge that we face is that the placenta is 
not routinely retained and examined in cases of NE re-
quiring TH. The overall placental histology capture rate 
in 2019 was 74% and the capture rate of the project 
from 2016-2019 is 76%. In simplistic terms, placental 
pathologies take place in the maternal plate, the fetal 
plate, or the cord. Of the available reports, the more 
common abnormalities encountered in the 2019 data 
were cord pathologies (34%), maternal vascular malp-
erfusion (12%), chorioamnionitis (10%) and fetal vascu-
lar malperfusion (8%). Multiple pathologies are com-
mon and study of patterns of placental damage can 
help understand fetal compromise. 
 
This year a small number of the results from the BSID-III 
carried out at 2 years were available. The application of 
this assessment remains inconsistent nationally and as 
such, due to the small numbers it is difficult to draw any 
conclusions and interpret trends and emerging themes 
at this point. It can be seen from this small cohort that 
both expressive communication and gross motor de-
velopment may require special attention when devis-
ing developmental guidelines for children who have 
been diagnosed with NE who have had TH. Funding 
has been approved and sites are in the process of hir-
ing suitable personnel to perform the BSID-III for TH 
infants. It is anticipated that accurate and consistent 
data will be captured once these roles have been filled. 
In conclusion there are a number of obstetric and ne-
onatal factors that should receive additional attention;
The obstetric factors that require consideration are; 
• The use of a standard fetal growth chart nationally
•  An agreed criteria for the standardised management 
of mothers from time of admission until the diagnosis 
of labour
• Agreed criteria for the diagnosis of labour
•  Documentation of a favourable cervix and Bishop 
score when undertaking an induction of labour
• Standardised interpretation of the CTG
• Standardised management of shoulder dystocia.
The neonatal factors that require consideration are; 
• Cord blood gases in every case
• Serum lactate measurement in every case 
• Daily documentation of the Sarnat score during TH 
•  The aEEG record to include the amplitude, presence 
or absence of seizures, the presence or absence of 
sleep/wake cycling during TH 
• Brain MRI by day 10 reported with the Barkovich score 
•  Retention and examination of the placenta in every 
case of TH. 
NE remains a challenging condition. The continued na-
tional dataset collection, however, provides an insight 
into how it can be tackled.
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•  NE is a significant cause of enduring 
morbidity and is the main cause of mortality 
in normally formed infants. The total 
mortality rate for infants in the TH cohort for 
the time period 2016-2019 was 14%.
•  During the years 2016-2019, 281 NE infants 
were treated with TH, indicating an incidence 
rate of 1.1 per 1,000 births. Consistent data 
collection, analysis, action and shared 
learning is needed to reduce the national 
incidence of NE requiring TH intervention.
•  Nulliparous mothers, induction of nulliparous 
mothers, shoulder dystocia, ethnicity and 
obesity with BMI >30 are risk factors for TH 
which require particular attention in their 
clinical management. 
•  There is a clear association with incidence of 
shoulder dystocia and the requirement for 
TH. Shoulder dystocia is more common in 
parous mothers in the general population of 
mothers giving birth. However, from 2016-
2019, 69% of the shoulder dystocia cases 
that required cooling occurred in nulliparous 
mothers.
•  The diagnosis of labour can be a challenge. 
The accurate and consistent application to 
diagnosing labour is warranted to ensure 
appropriate level of care and monitoring is 
provided to mothers and their infants. 
•  The antenatal detection of intrauterine 
growth restriction is important. During the 
four-year period 2016-2019, 17.4% of infants 
who underwent TH were small for dates 
(birthweight <10th centile) but not often 
detected at birth. 
•  Over the four year period, 40% of TH infants 
were born in a peripheral hospital and 
required transfer to one of the four tertiary 
centres that deliver TH intervention. The 
NNTP plays an important role in the retrieval 
of NE infants requiring TH intervention from 
peripheral hospitals. The data in this report 
reinforces that the Irish Health Service is 
providing TH in Ireland by way of continuum 
of care between referral hospital, NNTP and 
tertiary centres.
•  Good documentation is the platform 
for improvement in the assessment, 
categorisation, and management of infants 
with NE. Accurate clinical measurement is 
the best pathway to improved outcomes for 
this group of infants.
•  Through the 4 year national data collection 
on infants with NE, a number of recurring 
key performance indicators have emerged. 
In all cases of NE the following data items 
should be recorded:
 –  The cord blood gases, both arterial and 
venous.
 – First infant blood gas
 – The serum lactate in the first infant gas.
 – The Cooling Candidacy Checklist
 – The SARNAT score
 –  The aEEG findings- amplitude, sleep-wake 
cycling, seizures
 – The brain MRI scan report
 –  The categorisation of the grade of 
encephalopathy at the time of discharge.
 –  The placenta macroscopic and microscopic 
examination
 –  The BSID-III report for those infants who 
are now 2 years old.
Key Messages
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1.  Enhanced awareness of the important risk factors 
for NE (first time mothers, IUGR etc.) through stand-
ardisation of care pathways and multi-disciplinary 
training among front line staff is needed.
  The findings from this report provide additional infor-
mation to help improve the understanding of the risk 
factors associated with NE. Improving knowledge 
through the introduction of training programmes 
and tools for front line staff to help develop strate-
gies for minimising delays and initiating interventions 
if appropriate. This enhanced awareness should be an 
ongoing evaluation particularly in labour and take ac-
count of the rapidly changing environment.
2.  A National standardised assessment for the diag-
nosis of fetal growth restriction (FGR) is warranted 
and should include multi-disciplinary training.
  International evidence illustrates that suboptimal fe-
tal growth is linked to both short and long-term ad-
verse outcomes. Findings from this report illustrates 
there was some evidence of poor fetal growth with 
almost 20% of the infants born below the 10th cen-
tile. The establishment of a multidisciplinary working 
group to address a national standardised approach 
for the detection of FGR is warranted. 
3.  Multi-disciplinary skills and drills training to deal 
with obstetric sentinel events are required.
  Sentinel events; such as uterine rupture, placental 
abruption and shoulder dystocia, are acute events 
that are associated with NE. Training, with 2 yearly 
re-certifications, on the management of major ob-
stetric situations is required for all health profession-
als involved in the care of mothers in pregnancy.
4.  Front line staff responsible for CTG interpretation 
are recommended to undertake annual training.
  Fetal monitoring, including continuous cardiotocog-
raphy (CTG), requires expert knowledge and inter-
pretation and should be undertaken by skilled front 
line staff. The standardisation and the consistent ap-
plication of the interpretation of CTG and subsequent 
clinical response should be encouraged. The appoint-
ment of a National Fetal Monitoring and Obstetric 
Emergencies coordinator is advocated to provide na-
tional governance and training for CTG interpretation 
and Obstetric Emergency care with 2 yearly re-certi-
fication.
5.  Not all cases of TH can be avoided but some could 
be. A comprehensive review of each case of TH is 
recommended.
  Distinguishing between unavoidable, potential avoid-
able and avoidable cases of NE requiring TH is an im-
portant component for understanding the aetiology 
and reducing the frequency of TH cases. All cases of 
TH should have a robust review carried out locally 
initially. Appreciating that smaller hospitals may not 
be involved in the review process very frequently, a 
template has been developed to assist sites (see ap-
pendix A). 
6.  Umbilical cord blood gas measurements are re-
quired in every case where an infant requires TH.
  The findings from this report have indicated that cord 
blood gas measurements were not taken in 15% of 
cases. The cord blood gas measurements are an im-
portant part of the assessment in infants with NE re-
quiring TH and should be recorded in each case of 
NE.
7.  Serum lactate on the cord blood or first Infant blood 
gas for infants requiring TH.
  The anaerobic metabolism in response to hypox-
ia and poor tissue perfusion leads to an increase in 
the production of lactate. Raised serum lactate levels 
especially over 15 mmol/L can be a marker for ad-
verse outcome. In every case of NE, the serum lactate 
should be part of the infant’s assessment.
8.  The Neonatal Resuscitation Programme (NRP) cer-
tification is required for all midwives, nurses, and 
paediatric doctors working in maternity and neona-
tal units. 
  All midwives and neonatal staff engaged in the de-
livery and care of newborn infants should have up-
to-date instruction and training in neonatal resusci-
tation. The national NRP co-ordinator took up post 
in October 2020 to provide governance for the NRP 
programme within the 19 maternity units.
9.  The Cooling Candidacy Checklist should be used as 
the decision making tool in the evaluation of the in-
fant for therapeutic hypothermia.
  The Cooling Candidacy Checklist is the tool that 
should be applied when deciding to commence an 
infant on TH. The findings of the evaluation should be 
entered in the infant’s case notes. Our findings indi-
cate that it is only being used in 67% of cases. A copy 
of the checklist is included in this report (Appendix 
C)
10.  All infants receiving TH require a daily Sarnat as-
sessment during the three days of cooling.
  The Sarnat grading scale is an internationally rec-
ognised classification assessment tool for NE in the 
newborn infant. Daily assessment is necessary to as-
sess the progression of encephalopathy. The 2019 TH 
report similar to 2016/2017/2018 reports has found 
incomplete Sarnat assessment.
11.  All infants receiving TH require a daily aEEG report 
during the three days of cooling.
  The following aEEG parameters should be recorded 
daily during the period of cooling: Amplitude – Con-




The National Clinical Programme for Paediatrics 
and Neonatology (NCPPN) in collaboration with 
the National Perinatal Epidemiology Centre (NPEC) 
and the National Women and Infants Health Pro-
gramme (NWIHP) presents its successive report 
on neonatal TH in the Republic of Ireland for 2019. 
We now have four years 2016/2017/2018/2019 cu-
mulative comprehensive data to determine the 
current status and outcomes for infants who un-
derwent TH during this time frame.
This report presents the 2019 data alongside the 
2016/2017/2018 data for comparative analysis. By 
laying out the report in this format it is anticipated 
that patterns and trends will begin to emerge.
The electronic register was utilised in 2020 for TH 
data collection and will serve as a much needed 
platform to inform clinicians of identified mater-
nal and infant trends alongside clinical risk factors 
which will assist in the development of maternal 
risk profiles leading to a change in their antenatal 
and delivery management. Furthermore the e-reg-
ister will facilitate benchmarking of TH in Ireland 
against international standards and ensure contin-
uous quality improvement. TH is an evolving treat-
ment and by maintaining a constant record of the 
data on the e-register, the value of the adjunctive 
therapies during TH treatment can be accurately 









Assessment for Therapeutic Hypothermia









An e-learning programme on aEEG interpretation is 
available on the RCPI web site8. An appendix on the 
interpretation of aEEG is attached (Appendix D).
12.  Brain MRIs should be performed between days 5-10 
after birth and the reporting should be standardised 
using the Barkovich Score.
  Brain MRI is the modality of choice for assessment of 
brain injury severity in cases of NE. Timing of the MRI 
scan is important in the identification of the initial 
diffusion changes. If there is a delay in undertaking 
the scan the early findings can be missed because of 
pseudo normalisation. Standardisation of the reports 
using the Barkovich score is recommended. A copy 
of the Barkovich scoring system is attached (appen-
dix E).
13.  The retention of the placenta for histopathology ex-
amination in all cases where there was documented 
fetal distress during labour and/or the infant subse-
quently requires admission to the neonatal unit.
  The findings of this report indicate that placental ex-
amination is not being undertaken in 26% of cases 
requiring TH. Given that a decision to treat an infant 
with TH does not always occur at birth, it is recom-
mended that the placentas where there was docu-
mented fetal distress during labour are retained. 
With the increasing use of the Amsterdam criteria9,10 
for placental reporting, the potential for exploration 
of the associations of placental pathology, neonatal 
course and developmental outcome is enhanced. It is 
therefore critically important that placental submis-
sion rates in TH reach if not exceed the excellent rates 
of >95% achieved for stillbirth. 
 14.  BSID-III Neurodevelopmental follow-up.
  All TH infants should be followed up at 2 years of age 
with a BSID-III of their motor, cognitive, and speech/
language development. The aim is to make this eval-
uation available to all infants who have been treated 
with TH. Funding has been allocated for 3 new clini-
cal psychology posts to expand this service. 
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Methods
Purpose of this report
The primary aim of this report is to present an 
overview and national statistics on Neonatal TH 
in the Republic of Ireland for the year 2019. TH 
is administered in four centres only (National 
Maternity Hospital, Rotunda Hospital, Coombe 
Women and Infants University Hospital and 
Cork University Maternity Hospital). All babies 
born in other local and regional hospitals need-
ing this treatment are transferred to one of 
these four centres. 
The review will examine the clinical details 
around each case of Neonatal Therapeutic Hy-
pothermia. This will include the mothers’ ante-
natal details, labour and delivery. The infant’s 
resuscitation, neurological assessment, treat-
ment of seizures, the supportive clinical care 
the examination of the placenta and follow up 
data if applicable.
Data Collection
Retrospective reviews of inpatient medical re-
cords have been used as a gold standard ap-
proach when assessing multiple outcomes and 
rates of adverse events. Therefore, for the pur-
poses of the National Neonatal TH review, med-
ical records were considered the primary source 
of information. Data were collected on site and/
or via MNCMS in the 19 maternity units/hospi-
tals and neonatal intensive care units or special 
care baby units (NICU/SCBU) in the Republic 
of Ireland. The NCPPN, NPEC and NWIHP col-
lected data on all cases of neonatal therapeutic 
hypothermia in 2019 by taking an active case 
ascertainment approach. 
Processing of the data
Data on all infants who received TH were col-
lected on site in the 19 maternity units/hospitals. 
The data was uploaded to the electronic regis-
ter to the NPEC and were processed in a pseu-
donymised format. No hospital identifiers were 
included in the dataset, which means these data 
cannot be attributed to a specific hospital or to 
a specific individual. 
Missing data 
To ensure accuracy of information, missing 
or incomplete data were sought from the re-
spective maternity hospitals/units by the TH 
Co-Ordinator. For analysis purposes, cases with 
missing data were excluded from calculations. 
However, the extent of missing data is reported 
in the results section.
Continuous CTG review 
A review of CTGs was undertaken of the 59 in-
fants who had fetal monitoring undertaken in 
the one-hour period before delivery. During 
the review process a random sample of 16 in-
fants delivered in 2019 who did not require TH 
were included for the CTG group to review. The 
review group consisted of two consultant ob-
stetricians, one national lead midwife, one mid-
wifery manager and one senior obstetric reg-
istrar. For the review process, the group were 
given a short vignette and shown images of the 
CTG recorded in the one-hour period before 
delivery. The vignette provided included the 
following details when available; maternal age, 
parity, any documented pre-existing medical 
and or obstetric conditions, augmentation of la-
bour, length of labour and gestation at delivery. 
The full medical report including the partogram 
were not made available to the teams for this 
review process. Once the CTG was shown to the 
group, they had to document their decision be-
fore discussion began. The group were directed 
to categorise the CTG as; normal, suspicious, 
pathological or unsure request input from a 
colleague. Once the initial decision was doc-
umented by each group member a discussion 
then occurred amongst the group to achieve 
consensus. 
Comparison to National Statistics
Comparisons are made with the most recent 
publications available, including the Central 
Statistics Office’s Vital Statistics Fourth Quarter 




NE is a clinical condition in the term infant defined by abnormal neurological behaviour, with the onset 
occurring at or shortly after birth. 
NE is manifested by an abnormal level of consciousness, with or without the presence of seizures and is 
often accompanied by difficulty initiating and maintaining respirations, depressed tone and depressed 
reflexes, poor suck and swallow. 
NE incidence is estimated as 3.0 per 1000 live births and for Hypoxic-Ischaemic Encephalopathy (HIE) 
is 1.5 per 1,000 live births11. NE is graded as mild, moderate or severe using the Sarnat grading system. 
A subgroup of infants with NE have been exposed to a hypoxic-ischaemic insult in-utero and therefore 
they are assigned a diagnosis of HIE. In a proportion of these cases, a sentinel event is identified i.e. 
placental abruption, uterine rupture etc. 
TH has been found to be protective in those infants presenting with moderate or severe NE by inhibiting 
various events in this cascade of HIE injury. Major randomized clinical trials2–4 involving induced neo-
natal hypothermia have demonstrated a reduction in death and disability13–15. These trials have shown 
improved outcomes for babies with NE if they are cooled within six hours of birth to a targeted core 
body temperature of between 33°C to 34°C for a duration of 72 hours with rewarming to normothermic 
temperature occurring over a 6-12 hour period. TH is considered to be the standard of care for infants 
with moderate-to-severe NE who meet inclusion criteria.
  Suggested criteria for an intrapartum 
hypoxic-ischaemic insult12 include: 
(i)  Evidence of metabolic acidosis in fetal 
umbilical cord arterial blood obtained at 
delivery (pH < 7 and base deficit  
≥ 12 mmol/L).
(ii)  Early onset of severe or moderate NE in 
infants ≥ 34/40.
(iii)  A sentinel hypoxic event occuring 
immediately before or during labour e.g. 
uterine rupture, placental abruption, cord 
prolapse etc.
(iv)  A sudden and sustained fetal bradycardia or 
the absence of fetal heart rate variability in 
the presence of persistent late or persistent 
variable decelerations on cardiotocography, 
usually after a hypoxic sentinel event when 
the pattern was previously normal.
(v)  Apgar scores of 0-3 beyond 5 minutes of life.
(vi)  Onset of multisystem involvement within  
72 hours of birth.
(vii)  Early imaging study showing evidence of 
acute non-focal cerebral abnormality.
(viii)  Exclusion of other identifiable aetiologies  
e.g. trauma, coagulation disorders, infection 
or genetic disorders. 
The inclusion criteria for TH are;
• ≥36 weeks completed gestation with a 
weight ≥ 1800grams.
•  Acidosis (pH<7.0) present in the umbilical 
cord, or any blood sample taken within  
60 minutes of birth.
•  Base deficit ≥ -16.0 mmol/L in umbilical 
cord or any blood sample taken within  
60 minutes of birth.
•  History of acute perinatal event (such as 
but not limited to cord prolapse, placental 
abruption or uterine rupture).
•  Apgar score ≤5 at 10 minutes or at least 10 
minutes of positive-pressure ventilation. 
•  Evidence of moderate-to-severe 
encephalopathy, demonstrated by the 
presence of seizures OR at least one sign in 
three or more of the six categories shown In 
the Modified Sarnat Table (see Table 357). 
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Main Findings
The following analysis is based on 72 infants who underwent neonatal TH treatment in 2019.
Maternal Characteristics 
Age
The age of mothers whose infants underwent therapeutic hypothermia was known for all 72 of the mothers in 2019. 
The mothers whose infants underwent therapeutic hypothermia ranged in age from teenage years (the youngest 
being 18 years of age) through to mid-forties (the eldest being 44 years of age). Their age distribution reflected that 
of the population of mothers who gave birth in Ireland (Table 1). Two thirds of the population (65.6%)16 who gave 
birth between 2016 and 2019 were aged 30-39 years. As outlined in Table 2 there was no statistical difference in the 
risk of TH by maternal age. There were slight variations observed, with slightly higher risk among births to mothers 
aged under 25 years and lower risk for births to older mothers.
Table 1: Age distribution of mothers whose infants underwent therapeutic hypothermia in 2016-2019 versus all 
births in 2016-2019
Age group
TH cases  
N=63  
2016
TH cases  
N=77  
2017
TH cases  
N=68  
2018*
TH cases  
N=72  
2019
TH cases  
N=280  
2016-2019
All births16  
N=246,483  
2016-2019 (%)
<20yrs 1(1.6) 0(0.0) 3(4.4) 1(1.4) 5(1.7) 1.6
20-24yrs 8(12.7) 8(10.4) 7(10.3) 2(2.8) 25(8.3) 8.2
25-29yrs 9(14.3) 15(19.5) 10(14.7) 16(22.2) 50(17.9) 17.4
30-34yrs 23(36.5) 24(31.2) 25(36.8) 30(41.7) 102(36.4) 34.9
35-39yrs 18(28.6) 25(32.5) 18(26.5) 18(25.0) 79(28.2) 30.7
≥40yrs 4(6.3) 5(6.5) 5(7.4) 5(6.9) 19(6.8) 7.3
Note: Values are shown as N(%) unless otherwise stated. *Age unknown for one mother.  
Population data from the Central Statistics Office19 
Table 2: Risk ratios for infants who underwent therapeutic hypothermia in 2016-2019 by maternal age
Age group





Rate ratio  
(95% CI)
P-value
<20yrs 5(1.7) 1.26 (0.41-2.95) 1.21 (0.49-2.99) 0.679
20-24yrs 25(8.3) 1.24 (0.80-1.83) 1.19 (0.76-1.87) 0.449
25-29yrs 50(17.9) 1.17 (0.87-1.54) 1.12 (0.79-1.60) 0.531
30-34yrs 102(36.4) 1.19 (0.97-1.44) 1.14 (0.85-1.52) 0.394
35-39yrs 79(28.2) 1.04 (0.83-1.30) 1.00 (ref.)
≥40yrs 19(6.8) 1.06 (0.64-1.66) 1.02 (0.62-1.68) 0.948
Note: Values are shown as N(%) unless otherwise stated. *Age unknown for one mother. CSO data for births
15ANNUAL REPORT 2019
Ethnicity
Assessment of risk associated with ethnic group is impeded by the absence of national data on ethnicity for the 
pregnant population in Ireland. The majority of mothers whose infants underwent therapeutic hypothermia in 2019 
were of white Irish ethnicity (70.8%, n=51) (Table 3). This is similar to the proportion of white Irish women in the 
female population aged 15-49 years, enumerated by the National Census 2016. While the numbers involved were 
small, Irish Traveller, Asian and Black ethnicities were overrepresented in the mothers whose infants underwent 
therapeutic hypothermia in 2019 (16.7%) compared to 5.3% of the female 15-49-year-old population in the Irish 
Traveller, Asian and Black ethnicities from the National Census in 2016.
Table 3: Ethnicity of mothers whose infants underwent therapeutic hypothermia in 2016-2019 versus 15-49 




















White Irish 53(84.1) 52(69.3) 49(72.1) 51(70.8) 205(73.7) 79.2
Irish Traveller 0(0.0) 2(2.7) 1(1.5) 1(1.4) 4(1.4) 0.7
Other white background 6(9.5) 14(18.7) 12(17.6) 7(9.7) 39(14.0) 13.7
Asian/Asian Irish 4(6.3) 3(4.0) 2(2.9) 4(5.6) 13(4.7) 2.9
Black/Black Irish 0(0.0) 4(5.3) 3(4.4) 7(9.7) 14(5.0) 1.7
Other/mixed 0(0.0) 0(0.0) 1(1.5) 2(2.8) 3(1.1) 1.9
Note: Values are shown as N(%) unless otherwise stated. *Ethnicity unknown for two mothers.  
**Ethnicity unknown for one mother. ***Population data from the National Census 201617
Employment and insurance status
Table 4 provides a high-level overview of the data provided on mother’s employment status, alongside data 
available for the most comparable occupation categories for mothers of all births in Ireland17 and for the 15-44 year-
old female population from the National Census 2016. Employment status was specified for all of the mothers for 
whom data were recorded in 2019 (100%; n=72). It can be seen that unemployed status was recorded for 5.8% of 
the mothers whose infants underwent therapeutic hypothermia compared to 4.5% of all mothers in 2016 and 8.2% 
of the female population aged 15-44 years (Table 4). The proportion of mothers engaged in home duties whose 
infants underwent therapeutic hypothermia (15.3%) was lower than the percentage of all women engaged in home 
duties who gave birth in 2016 (20.5%). 
Health insurance status was recorded for the 72 mothers whose infants underwent therapeutic hypothermia in 2019 
and for 65 of the 69 mothers whose infants underwent therapeutic hypothermia in 2018. In total, 90% of these 
mothers were public patients (n=123 of 137, 89.8%) while 10% attended a consultant obstetrician privately (n=14, 
10.2%). This shows an over-representation of public patients among mothers whose infants underwent therapeutic 
hypothermia as, according to HIPE data, 82.0% and 18.0% of all mothers who gave birth in hospital in 2018-2019 
were public and private patients, respectively. The risk of TH for the infants of public patients was 1.28 (95% CI=1.06-
1.52) per 1,000 women, which was almost twice the risk of 0.66 (95% CI=0.36-1.11) per 1,000 women among private 
patients (Risk ratio=1.93, 95%=1.11-3.36, p-value=0.020).
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Table 4: Employment status at booking of mothers whose infants underwent therapeutic hypothermia in 2016-
























Employed 43(81.1) 48(73.8) 49(74.2) 53(73.6) 193(75.4) 73.1 57.8
Unemployed 1(1.9) 10(13.0) 11(16.7) 4(5.8) 26(10.2) 4.5 8.2
Home duties 5(1.9) 4(5.2) 3(4.5) 11(15.3) 23(9.0) 20.5 10.4
Student 4(7.5) 3(3.9) 3(4.5) 3(4.2) 13(5.1) n/a 21.1
Others not in 
labour force
0(0.0) 0(0.0) 0(0.0) 1(1.4) 1(0.4) n/a 2.5
Note: *Data not known on employment for 10 mothers. **Data not known on employment for 12 mothers.  
***Data not known on employment for 2 mothers. +Population data from the National Census 201617 
Body Mass Index
Body Mass Index (BMI) was available for 69 of the 72 mothers whose infants underwent therapeutic hypothermia in 
2019 (Table 5). The pattern of BMI in the mothers was similar to that from the general population who participated 
in the 2019 Healthy Ireland Survey18. The BMI of 31.9% of these mothers was in the obese range (>30.0kgm-2), which 
is higher than those from the general population.
Table 5: Body mass index of mothers whose infants underwent therapeutic hypothermia in 2016-2019 versus 


















Survey 2019  
(%)18
Underweight (<18.5) 1(1.6) 2(2.8) 0(0.0) 0(0) 3(1.1) 1
Healthy (18.5-24.9) 22(35.5) 33(45.8) 23(37.1) 30(43.5) 108(41.2) 44
Overweight (25.0-29.9) 22(35.5) 20(27.8) 19(30.6) 17(24.6) 78(29.8) 33
Obese (>30.0) 17(27.4) 17(23.6) 20(32.3) 22(31.9) 73(27.9) 22
Note: Values are shown as N(%) unless otherwise stated. *BMI value missing for six mothers.  
**BMI value missing for five mothers. ***BMI value missing for three mothers.
Smoking and substance abuse
Of the 72 mothers whose infants underwent therapeutic hypothermia in 2019, nine mothers (12.5%) were smokers 
at the time of booking; this is slightly lower than the prevalence of all female smokers in the Irish population in 2018 
(17%)11. Information on smoking was available for seven of the nine smokers (77.8%). Four mothers were smoking 
between 1 and 5 cigarettes per day (n=4 of 7, 57.1%) and three were smoking between 11 and 20 cigarettes per day 
(n=3 of 7, 42.9%). Of the seven mothers who were smoking at booking, none of the mothers stopped smoking 
during pregnancy. There were no pregnancies with a documented history of alcohol abuse, but one woman had a 
documented history of drug abuse who used cannabis during pregnancy.
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Previous pregnancy 
In terms of parity of mothers who delivered infants requiring TH in 2019, there was an overrepresentation of mothers 
who had not previously delivered (59.7%) compared to the general population of mothers who gave birth in 2016 
(38.2%; Table 6). Table 7 outlines the risk of TH among infants born to multiparous mothers, with little variation 
between the numbers of previous deliveries. 
Considering all infants born to multiparous mothers as one group, there were 115 cases of TH in 2016-2019 and their 
risk of TH was 0.75 (95% CI=0.62-0.91) per 1,000 births. Compared to these infants, the risk of TH was 2.34 times 
higher among those born to nulliparous mothers (Risk ratio=2.34, 95% CI=1.84-2.97, p-value<0.001).
Table 6: Distribution of parity, 2016-2019
Parity
TH cases  
N=63  
2016
TH cases  
N=77  
2017
TH cases  
N=69  
2018
TH cases  
N=72  
2019
TH cases  
N=281  
2016-2019
All births*  
2016-2019  
(%)
Nulliparous 42(66.7) 42(54.5) 39(56.5) 43(59.7) 166(59.1) 38.2
Para 1 13(20.6) 21(27.3) 19(27.5) 14(19.4) 67(23.8) 34.9
Para 2 5(7.9) 8(10.4) 7(10.1) 8(11.1) 28(10.0) 17.8
Para 3+ 3(4.8) 6(7.8) 4(5.8) 7(9.7) 20(7.1) 9.1
Note: Values are shown as N(%) unless otherwise stated. **Population data from the Central Statistics Office19







Rate ratio  
(95% CI)
P-value
Nulliparous 166(59.1) 1.76 (1.51-2.05) 2.77 (1.85-4.13) <0.001
Para 1 67(23.8) 0.78 (0.60-0.99) 1.22 (0.78-1.90) 0.378
Para 2 28(10.0) 0.64 (0.42-0.92) 1.00 (ref.)
Para 3+ 20(7.1) 0.90 (0.55-1.38) 1.40 (0.79-2.49) 0.246
In 2019, 40 mothers had a previous pregnancy. Of these, 33.3% (n=13 of 39; undocumented for one) had a 
previous pregnancy-related problem reported. As outlined in Table 8, mothers who had experienced three or more 
miscarriages and having an infant who previously required intensive care were both the most common pregnancy-
related problem in mothers who had a previous pregnancy (10%; n=4). None of the mothers had an infant with HIE 
in a previous pregnancy.
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Table 8: Previous pregnancy-related problems in mothers whose infants underwent therapeutic hypothermia in 
2019
TH cases  
N=28  
2016
TH cases  
N=47  
2017
TH cases  
N=30  
2018
TH cases  
N=40  
2019
TH cases  
N=145  
2016-2019*
Previous caesarean delivery 6(21.4) 8(17.0) 6(20.0) 3(7.5) 23(15.9)
Three or more miscarriages 1(3.6) 4(8.5) 1(3.3) 4(10.0) 10(6.9)
Infant requiring intensive care 0(0.0) 3(6.4) 2(6.7) 4(10.0) 9(6.2)
Pre-term birth or mid-trimester loss 2(7.1) 1(2.1) 0(0.0) 1(2.5) 4(2.8)
Neonatal death 1(3.6) 0(0.0) 1(3.3) 0(0.0) 2(1.4)
Pre-eclampsia 2(7.1) 0(0.0) 0(0.0) 1(2.5) 3(2.1)
Stillbirth 1(3.6) 1(3.6) 1(3.3) 0(0.0) 3(2.1)
Placenta abruption 0(0.0) 1(2.1) 2(6.7) 0(0.0) 3(2.1)
Post-partum haemorrhage requiring 
transfusion
0(0.0) 0(0.0) 1(3.3) 0(0.0) 1(0.7)
Infant with congenital anomaly 0(0.0) 0(0.0) (0.0) 1(2.5) 1(0.7)
Other 0(0.0) 1(2.1) 2(6.7) 3(7.5) 6(4.1)
Placenta praevia 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Previous infant with HIE 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Note: *Percentage relates to total number of mothers who had a previous pregnancy (n=145). Categories are not mutually 
exclusive. Values are shown as N(%) unless otherwise stated 
Pre-existing medical problems
Almost half of the mothers, whose infants underwent TH in 2019, had one or more pre-existing medical problems 
(n=35, 48.6%). Twenty-one of the 72 mothers were taking prescribed medication during the pregnancy (29.2%). Six 
mothers had a documented family history of conditions which can affect newborn infants (8.3%; n=6). The most 
common type of pre-existing medical problems were endocrine disorders, with 18.1% of mothers (n=13) suffering 
from conditions of this type (Table 9). Psychiatric disorders had the second highest percentage of occurrence 
(6.9%, n=5). 
Table 9: Pre-existing medical problems in mothers whose infants underwent therapeutic hypothermia in 2019
TH cases  
N=63  
2016
TH cases  
N=77  
2017
TH cases  
N=69  
2018
TH cases  
N=72  
2019
TH cases  
N=281  
2016-2019
Endocrine disorder 7(11.1) 3(3.9) 6(8.7) 13(18.1) 29(10.3)
Psychiatric disorder 4(6.3) 3(3.9) 6(8.7) 5(6.9) 18(6.4)
Hypertension 3(4.8) 1(1.3) 0(0.0) 1(1.4) 5(1.8)
Haematological disorder 1(1.6) 2(2.6) 0(0.0) 0(0.0) 3(1.1)
Diabetes 1(1.6) 1(1.3) 1(1.4) 0(0.0) 3(1.1)
Cardiac disease 0(0.0) 1(1.3) 1(1.4) 3(4.2) 5(1.8)
Inflammatory disorder 0(0.0) 1(1.3) 0(0.0) 0(0.0) 1(0.3)
Renal disease 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Epilepsy 0(0.0) (0.0) 2(2.9) 2(2.8) 4(1.4)
Other 7(11.1) 18(23.4) 9(13.0) 17(23.6) 51(18.1)
Note: Percentage relates to total number of mothers, categories are not mutually exclusive  
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Antenatal care 
Currently in Ireland, there is no national data on the number of births as a result of fertility treatment. Information 
was available for all of the mothers whose infants underwent therapeutic hypothermia in 2019. In five of these cases 
(6.9%), the pregnancy was reported to be the result of fertility treatment. In vitro fertilisation was the method of 
fertility treatment specified for three of the five pregnancies and over half of these mothers were aged 40 years or 
older (60.0%; n=3 of 5). In terms of parity the majority of mothers were nulliparous (80.0%; n=4 of 5).
During this pregnancy, the majority of the 72 mothers intended on delivering in an obstetric unit (95.8%; n=69) 
with obstetric-led care (88.9%; n=64). Gestation at booking was unknown for one woman and no mothers were 
unbooked in 2019 (Table 10). A third of mothers had their first antenatal appointment before 12 weeks gestation 
(36.1%; n=26) and over half of the mothers between 12 and 15 weeks gestation (55.6%; n=40). Estimated Date of 
Delivery (EDD) was documented for all 72 of the mothers. EDD was confirmed using ultrasound scan in the majority 
of cases (95.8%; 69 of 72). 
Table 10: Timing of antenatal hospital booking appointment for mothers whose infants underwent therapeutic 
hypothermia in 2016-2019
TH cases  
N=63  
2016
TH cases  
N=77  
2017
TH cases  
N=69  
2018
TH cases  
N=72  
2019
TH cases  
N=281  
2016-2019
Less than 12 weeks 16(25.4) 22(28.6) 14(20.3) 26(36.1) 78(27.8)
12-15 weeks 40(63.5) 40(51.9) 40(58.0) 40(55.6) 160(56.9)
15-19 weeks 5(7.9) 9(11.7) 7(10.1) 3(4.2) 24(8.5)
20 weeks of later 2(3.2) 2(2.6) 1(1.6) 2(2.8) 7(2.5)
Unknown 0(0.0) 4(5.2) 5(7.2) 1(1.4) 10(3.6)
Unbooked 0(0.0) 0(0.0) 2(2.9) 0(0.0) 2(0.7)
Note: Values are shown as N(%) unless otherwise stated. *Missing data for one mother 
Gestation at last antenatal hospital visit
Information on the last antenatal visit was available for 69 of the 72 mothers whose infants underwent TH in 2019 
(95.8%). These 69 mothers last attended the hospital clinic between 28 and 41 weeks. The majority of mothers 
attended at 37 weeks or later (88.4%, n=61 of 69) with 17.4% (n=12 of 69) last attending the hospital before the last 
routine antenatal clinic visit at 37 weeks gestation (Figure 1). Two of these 12 mothers (16.7%) were reported to have 
missed antenatal appointments as they did not attend on multiple occasions. Of the 72 mothers, one mother was 
transferred from another maternity unit with the fetus in utero at 22 gestational weeks.
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Concern documented during pregnancy
Of the 72 cases, there were concerns documented during the pregnancy for 28 (38.9%) of the mothers whose 
infants underwent therapeutic hypothermia in 2019. Three of these mothers had two or more concerns documented 
(17.9%; n=5 of 28). The most common concern documented was gestational diabetes mellitus with 11.1% (n=8 of 
72) of mothers developing this condition during pregnancy. This was followed by suspected intrauterine growth 
restriction and hypertensive disorders which both had the second highest percentage of occurrence (6.9%, n=5 of 
72 respectively). Concern over non-attendance at antenatal appointments was the fourth most common concern 
documented for these pregnancies (4.2%; n=3 of 72). 
Labour 
Information on the onset of labour was available for all 72 mothers whose infants underwent TH in 2019 (Table 11). 
Almost half of the mothers laboured spontaneously (45.8%; n=33), over a third of mothers were induced (36.1%; 
n=26) and 18.1% of mothers were never in labour. 




















Spontaneous 135(48.0) 19(45.2) 22(52.4) 19(48.7) 17(39.5) 10(47.6) 18(51.4) 14(46.7) 16(55.2)
Induction 97(34.5) 22(52.4) 13(31.0) 12(30.8) 17(39.5) 6(28.6) 7(20.0) 11(36.7) 9(31.0)
Never in labour 49(17.4) 1(2.4) 7(16.7) 8(20.5) 9(20.9) 5(23.8) 10(28.6) 5(16.7) 4(13.8)
Note: Values are shown as N(%) unless otherwise stated 
As outlined in Table 12, over half of mothers who laboured spontaneously presented to the emergency department 
(51.5%, n=17 of 33). Of these mothers, the majority presented with either spontaneous rupture of membranes (n=8 
of 33) or spontaneous onset of labour (n=15 of 33). 
Of the 26 mother who were induced, 23 of those were planned inductions (88.5%; n=23 of 26) with the majority of 
mothers presenting to the antenatal ward for admission for delivery (84.6%; n=22 of 26). 
Table 12: The department that mothers attended when presenting to the hospital for admission for queried 











Maternity Emergency Department 28(39.9) 17(51.5) 2(7.7) 9(69.2)
Antenatal Wards 29(40.3) 5(15.2) 22(84.6) 2(15.4)
Labour Wards 10(13.9) 7(21.2) 2(7.7) 1(7.7)
Other 5(6.9) 4(12.1) 0(0.0) 1(7.7)
Note: Values are shown as N(%) unless otherwise stated.
For the first time in 2019, documented times were sought relating to when the mother was admitted to hospital, 
diagnosed as being in labour, admitted to the labour ward, when she began to push and when the baby was born. 
Twenty-five of the 33 mothers with spontaneous onset of labour had data available for most of these stages. Half 
of the 25 mothers had their labour diagnosed within approximately one hour of their admission to hospital (n=13, 
52.0%), 5 mothers (20.0%) had their labour diagnosed approximately two hours after hospital admission and for the 
other 7 mothers (28.0%) labour diagnosis was made 5-22 hours after admission to hospital.
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The mean time from labour diagnosis to labour ward admission was 47 minutes (Table 13; data available for 18 of the 
20 mothers). On average, time from labour diagnosis to labour ward admission was longer for nulliparous mothers. 
The mean time from labour ward admission to starting to push was almost four hours. The mean time was twice as 
long for nulliparous mothers, at approximately five hours versus two and a half hours for parous mothers. Time from 
starting to push until delivery of the baby was 33 minutes, on average. Again, this varied by parity, with a mean of 
53 minutes for nulliparous mothers and 15 minutes for parous mothers. 
Table 13: Mean time of stages of labour for mothers with spontaneous onset of labour in 2019
Stage n All Nulliparous Parous
From labour diagnosis to labour ward admission 18 00:47 01:12 00:21
From labour ward admission to starting to push 18 03:45 04:53 02:37
From starting to push to delivery of the baby 21 00:33 00:53 00:15
Note: n represents the number of mothers with data available. Time values are in the format hh:mm.
Half of the mothers who laboured spontaneously had their labour accelerated (50.0%; n=16 of 32, missing data for 
one mother), either by artificial rupture of membranes (ARM; 56.3%, n=9 of 16) or oxytocin (31.3%; n=5 of 16). Two 
mothers (12.5%; n=2 of 16) had their labour accelerated with both (Table 14).




















ARM 34 3(27.3) 6(54.5 4(44.4) 4(40.0) 3(100) 5(100) 4(66.7) 5(83.3)
Oxytocin 22 8(72.7) 5(45.5) 2(22.2) 4(40.0) 0(0.0) 0(0.0) 2(33.3) 1(16.7)
Both 5 0(0.0) 0(0.0) 3(33.3) 2(20.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Note: Values are shown as N(%) unless otherwise stated 
As outlined in Table 15, liquor was clear in 37 of the 56 documented cases (66.1%). One in every four mothers had 
meconium-stained liquor (28.6%; n=16 of 56). The grade of meconium was specified for 15 of the 16 cases (93.8%), 
with 46.7% of these mothers having Grade 1 (n=7 of 15), 26.7% of mothers having Grade 2 (n=4 of 15) and the 
remaining four mothers having Grade 3 (26.7%).




















Clear 132(47.0) 22(52.4) 19(45.2) 16(41.0) 25(58.1) 11(52.4) 16(45.7) 11(36.7) 12(41.4)
Meconium 71(25.3) 11(26.2) 10(23.8) 14(35.9) 7(16.3) 2(9.5) 8(22.9) 10(33.3) 9(31.0)
Other 23(8.3) 5(11.9) 5(11.9) 4(10.3) 2(4.7) 0(0.0) 2(5.7) 4(13.3) 1(3.4)
Missing/ 
Non-applicable 
55(19.6) 4(9.5) 8(19.0) 5(12.8) 9(20.9) 8(38.1) 9(25.7) 5(16.7) 7(24.1)
Note: Values are shown as N(%) unless otherwise stated 
22 NEONATAL THERAPEUTIC HYPOTHERMIA IN IRELAND
Induction
There was a documented reason for induction for 22 of the 26 mothers whose onset of labour was induced (84.6%). 
As indicated in Table 16, the common reasons to induce labour were associated with post maturity (40.9%%; n=9 
of 22), hypertensive disorders (13.6%; n=3 of 22) and large for gestational age (9.1%; n=2 of 22). Under the “Other” 
category a range of indications were captured including; gestational diabetes mellitus and previous pregnancy 
complications. 








Post maturity 9(40.9) 9(56.3) 0(0.0)
Hypertensive disorders 3(13.6) 2(12.5) 1(16.7)
Large for gestational age 2(9.1) 1(6.3) 1(16.7)
Oligohydramnios 1(4.5) 0(0.0) 1(16.7)
Polyhydramnios 1(4.5) 0(0.0) 1(16.7)
Intra-uterine growth restriction 1(4.5) 1(6.3) 0(0.0)
Prolonged SROM 1(4.5) 1(6.3) 0(0.0)
Reduced fetal movements 1(4.5) 1(6.3) 0(0.0)
Other 6(27.3) 3(18.8) 3(50.0)
Note: Values are shown as N(%) unless otherwise stated. *Categories are not mutually exclusive 
It was documented that all 26 mothers who were induced had a cervical assessment carried out (100%, Table 17). 
The result of the assessment was undocumented in over a quarter of cases (26.9%; n=7 of 26). Almost one quarter 
of mothers had a favourable result (23.1%; 6 of 26) with similar rates observed for nulliparous and parous mothers 
(23.5%; n=4 of 17 versus 22.2%; n=2 of 9 respectively). The Bishop score was used for 21 of the 26 mothers who were 
induced (80.8%). Of these 21 mothers, the median Bishop score was 2 and these scores ranged from 1 to 8.
Table 17: Results of the cervical assessment carried out on mothers who were induced whose infants underwent 









Favourable 6(23.1) 4(23.5) 2(22.2)
Not favourable 3(11.5) 2(11.8) 1(11.1)
Neither 10(38.5) 8(47.1) 2(22.2)
Not documented 7(26.9) 3(17.6) 4(44.4)
Bishop Score N=21 N=14 N=7
0-6 20(95.2) 14(100) 6(85.7)
7-10 1(4.8) 0(0.0) 1(14.3)
Note: Values are shown as N(%) unless otherwise stated  
The method of induction was known for all 26 mothers who were induced in 2019 (100%). Two thirds of mothers 
had their labour induced using multiple methods of induction (65.4%; 17 of 26). As illustrated in Table 18, two thirds 
of mothers had their labour induced with the artificial rupture of membranes (65.4%; n=17 of 26). The second most 
common method of induction was the use of prostaglandin gel (61.5%; n=16 of 26) followed by oxytocin (46.2%; 
n=12 of 26).
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Oxytocin 55(56.7) 14(63.6) 9(69.2) 7(58.3) 8(47.1) 2(33.3) 4(57.1) 7(63.6) 4(44.4)
Artificial rupture of 
membranes
54(55.7) 11(50.0) 8(61.5) 6(50.0) 11(64.7) 4(66.7) 4(57.1) 4(36.4) 6(66.7)
Prostaglandin gel 52(53.6) 12(54.5) 6(46.2) 7(58.3) 12(70.6) 4(66.7) 2(28.6) 5(45.5) 4(44.4)
Propress 24(24.7) 6(27.3) 6(46.2) 4(33.3) 4(23.5) 0(0.0) 1(14.3) 1(9.1) 2(22.2)
Other 1(1.0) 1(4.5) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive.
Never in labour
In 2019, there was a similar proportion of nulliparous mothers (20.9%; n=9 out of 43) who were never in labour 
compared to parous mothers (13.8%; n=4 of 29) which was lower than the previous years (Table 11). The figures 
for 2016-2018 reported that 13.0% of nulliparous mothers (n=16 of 123) and 23.3% of parous mothers (n=20 of 86) 
whose infants underwent TH were never in labour. Of the 13 mothers who were never in labour in 2019, two mothers 
had previously had a caesarean section (15.4%; n=2 of 13), which is consistent with the mothers from 2016-2018 
(14.9% n=7 of 47). Half of the mothers who were never in labour in 2019 had a reported medical problem during 
this pregnancy (46.2%; n=6 of 13) which included endocrine disorder, psychiatric disorder, hypertension, asthma, 
sexually transmitted infection and arthrogryposis. The indication for admission to the hospital was recorded for all 
13 mothers. 
One quarter of mothers who were never in labour were admitted complaining of reduced fetal movements (23.1%; 
n=3 of 13) and a further one quarter of woman were admitted with a query of spontaneous labour (30.1%; n=4 of 
13). The indication for caesarean section was recorded for all 13 mothers, with half due to a non-reassuring CTG in 
2019 (53.8%, n=7 of 13) which is lower than the 74.5% (n=37 of 47) of mothers between 2016 and 2018. One-quarter 
of mothers were brought to theatre for caesarean section in 2019 due to placental abruption (23.1%, n=3 of 13) 
compared to 8.5% (n=4 of 47) between 2016 and 2018. Of the remaining three mothers in 2019, the indication for 
caesarean section included antepartum haemorrhage, eclamptic seizures and one woman with a planned caesarean 
section.
Fetal heart monitoring 
Fetal heart monitoring was undertaken for 68 of the 72 mothers whose infants underwent TH in 2019 (94.4%). The 
method of fetal heart monitoring was documented for all 68 mothers (100%). As illustrated in Table 19, external 
continuous fetal heart monitoring was the most common method of monitoring used during labour (91.2%; n=62 of 
68). Seven mothers who underwent external continuous fetal heart monitoring also had internal continuous fetal 
heart monitoring (11.3%; n=7 of 62). Two thirds of all mothers who had fetal monitoring undertaken had external 
intermittent fetal heart monitoring (63.2%; n=43 of 68). Of these mothers, the majority also underwent external 
continuous fetal heart monitoring during labour (86.0%; n=37 of 43).




















External continuous 205(85.8) 36(90.0) 26(76.5) 36(97.3) 37(88.1) 9(69.2) 15(65.2) 21(87.5) 25(96.2)
External intermittent 105(43.9) 16(40.0) 10(29.4) 11(29.7) 28(66.7) 5(38.5) 9(39.1) 11(45.8) 15(57.7)
Internal continuous 23(9.6) 1(2.5) 2(5.9) 6(16.2) 4(9.5) 0(0.0) 1(4.3) 6(25.0) 3(11.5)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive 
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Data on cardiotocography (CTG), which could be interpreted, were available for 59 of the 62 cases (93.7%) who 
had external continuous fetal heart monitoring. Of these 59, one in five were interpreted as suspicious (20.3%; n=12 
of 59) and almost three quarters were interpreted as pathological (71.2%; n=42 of 59). One fetal blood sample 
was taken for four of the 72 infants who underwent TH in 2019 (5.6%). One in four of the fetal blood samples was 
categorised as abnormal (25.0%; n=1 of 4). 
Delivery
Information on both the day and time of birth was available for all 72 infants who underwent TH in 2019. The timing 
of birth was categorised between 08:00 and 19:59 hours and 20:00 and 07:59hrs. As illustrated in Figure 2, the time 
of birth varied across the seven days of the week. One third of infants who underwent TH in 2019 were born at the 
weekend or on a bank holiday (33.3%; n=24). Of all of these births, two thirds were born between 20:00 and 07:59 
hours (65.3%; n=47).
Figure 2: Day of week and time of birth (08:00 – 19:59 and 20:00 – 07:59) for infants who underwent 
therapeutic hypothermia in 2019 
The type of care received at delivery was known for all mothers whose infants underwent TH (n=72). The vast 
majority of the infants (97.2%; n=70) were delivered under obstetric-led care, which is the predominant model of 
care in Ireland. Two infants were born before arrival at the maternity unit.
Presentation at delivery was known for 96.6% of mothers who laboured before delivery (n=57 of 59). The majority 
of presentations at delivery were vertex presentations (n=52 of 57, 91.2%), and in three cases the presentation was 
breech (n=3 of 57, 5.3%). 
Mode of delivery was known for all mothers (n=72) whose infants underwent TH in 2019 (Table 20). One in five of 
infants had a spontaneous vaginal delivery (33.4%, n=24), which is considerably lower than the proportion of vaginal 
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One third of the deliveries were instrumental (33.3%, n=24 of 72), with four mothers who had a combination of a 
ventouse and a forceps delivery. The interval time from decision to the instrumental delivery was known in 21 of the 
22 cases. The median interval time to delivery was 5 minutes and ranged from one to 12 minutes. 
Caesarean section was the most common mode of delivery for all 72 of these infants (37.5%, n=27), with a slightly 
higher proportion of caesarean sections happening pre-labour (48.1%, n=13 of 27) rather than after the onset of 
labour (51.9%, n=14 of 27). 
Three mothers had a caesarean section following failed instrumental deliveries. The interval time between attempting 
and the decision to abandon the instrumental delivery was between 5 and 16 minutes for these three mothers. The 
interval time from the abandonment of the instrumental delivery to caesarean section was between 15 and 26 
minutes for these three mothers.






























Assisted breech 0(0.0) 0(0.0) 0(0.0) Assisted breech 0.1%
Ventouse** 19(26.4)** 13(30.2) 6(20.7) Ventouse 11.2%
Forceps 9(12.5) 7(16.3) 2(6.9) Forceps 3.7%
Note: Values are n(%) unless otherwise stated. Categories are not mutually exclusive. +Vaginal births in this category include mothers 
who had both a Spontaneous Vaginal Cephalic and a Spontaneous Vaginal Breech delivery. ++Caesarean section in this category 
include mothers who had a pre-labour caesarean section as well as mothers who had a caesarean section after the onset of labour. 
*Three mothers had a caesarean section following failed instrumental deliveries. **Four mothers who had a ventouse delivery, also 
had a forceps delivery. ***All births data are based on HIPE data and therefore relate to all mothers who gave birth in hospital rather 
than all births. The value for forceps includes mothers whose delivery involved both Ventouse and forceps. 
The type of caesarean section was documented for all 27 mothers (Table 21). One mother whose infant underwent 
TH in 2019 had an elective caesarean section (3.7%; n=1 of 27). Ten mothers had an urgent caesarean section (37.0%; 
n=10 of 27). Emergency caesarean section delivery was the most common type of caesarean section delivery, 
accounting for 59.3% of cases where the infant was delivered by caesarean section (n=16 of 27). Of the mothers 
who had an emergency caesarean section delivery, 56.3% (n=9 of 16) were pre-labour and 43.7% (7 of 16) occurred 
after the onset of labour. 








Elective – planned 1(3.7) 1(5.1) 0(0.0)
Urgent – maternal or fetal compromise which is not immediately 
life threatening
10(37.0) 8(42.1) 2(25.0)
Emergency – immediate threat to life of woman or fetus 16(59.3) 10(52.6) 6(75.0)
For mothers who had their labours induced, almost half had an instrumental delivery (46.2%; n=12 of 26). As outlined 
in Table 22, induced parous mothers were almost twice as likely to deliver vaginally compared to induced nulliparous 
mothers (44.4%; n=4 of 9 versus 23.5%; n=4 of 17).
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Vaginal delivery 8(30.7) 4(23.5) 4(44.4)
Caesarean Section* 7(26.9) 5(29.4) 2(22.2)
Ventouse** 7(26.9) 5(29.4) 2(22.2)
Forceps 6(23.1) 5(29.4) 1(11.1)
Note: Values are N(%) unless otherwise stated. Categories are not mutually exclusive. *One mother had a caesarean section 
following failed instrumental deliveries. **One mothers who had a ventouse delivery, also had a forceps delivery 
Other incidents at birth and following delivery
As outlined in Table 23, 12.5% of mothers whose infants underwent TH had a shoulder dystocia (n=9). In 2019, one 
in ten mothers experienced maternal pyrexia during labour (n=7).
Table 23: Other incidents at the birth of infants who underwent therapeutic hypothermia in 2016-2019
TH cases  
N=63  
2016
TH cases  
N=77  
2017
TH cases  
N=69  
2018
TH cases  
N=72  
2019
TH cases  
N=281  
2016-2019
Maternal pyrexia in labour 14(22.2) 12(15.6) 3(4.3) 7(9.7) 36(12.8)
Shoulder dystocia 10(15.9) 8(10.4) 9(13.0) 9(12.5) 36(12.8)
Prolonged rupture of membranes 7(11.1) 7(9.1) 9(13.0) 3(4.2) 26(9.3)
Meconium aspiration 4(6.3) 11(14.3) 0(0.0) 4(5.6) 19(6.8)
Subgaleal haematoma 1(1.6) 2(2.6) 0(0.0) 1(1.4) 4(1.4)
Spontaneous premature labour 0(0.0) 1(1.3) 0(0.0) 0(0.0) 1(0.4)
Birth trauma 1(1.6) 0(0.0) 0(0.0) 0(0.0) 1(0.4)
Other 3(4.8) 2(2.6) 2(2.9) (0.0) 7(2.5)
Note: Values are shown as N (%) unless otherwise stated. Categories are not mutually exclusive
Shoulder dystocia infants
Shoulder dystocia was reported as affecting the delivery of nine of the 72 infants (12.5%) who received TH in 2019, 
which is similar to the previous three years. In total, shoulder dystocia was associated with the delivery of 36 of the 
281 infants (12.8%) who received TH in 2016-2019. In contrast, shoulder dystocia was diagnosed for 0.8% (n=1,855) of 
the population of 240,472 mothers who gave birth in hospital in 2016-2019 according to HIPE data. Based on these 
data, the risk of an infant receiving TH was 19.4 (95% CI=13.6-26.9) per 1,000 women if the delivery was affected by 
shoulder dystocia compared to 1.0 (95% CI=0.9-1.2) per 1,000 women if there was no reported should dystocia, a 
19-fold difference (Risk ratio=18.90, 95% CI=13.32-26.82, p-value<0.001).
Table 24 details maternal, infant and delivery characteristics for the 36 cases of TH associated with shoulder dystocia 
compared to the other 245 cases during 2016-2019. Cases associated with shoulder dystocia were similar to other 
cases with respect to maternal age (p-value=0.982) and mode of delivery (p-value=0.499). The preponderance of 
nulliparous mothers was more evident among cases associated with shoulder dystocia but this was not statistically 
significant (p-value=0.175). More pronounced differences were observed related to overweight/obesity (77.8% vs. 
55.2%, p-value<0.011), induction of labour (58.3% vs. 31.0%; p-value=0.001) and birthweight (55.6% ≥4kg vs. 13.9%, 
p-value<0.001; 30.6% ≥90th centile vs. 7.8%, p-value<0.001).
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The most common manoeuvre utilised for deliveries with shoulder dystocia was a combination of McRoberts and 
suprapubic pressure (n=25 of 36, 69.4%). Twenty-nine of the 36 mothers had an instrumental delivery (80.6%). Time 
between decision to use instrumentation and delivery of the baby was recorded for the TH cases with shoulder 
dystocia in 2019. The median time was 5 minutes and the range was 1-12 minutes.
Table 24: Maternal, infant and delivery characteristics for deliveries with and without shoulder dystocia
Characteristic
Cases with shoulder 
dystocia in 2019
N=9









<30yrs 2(22.2) 10(27.8) 70(28.7)
30-34yrs 4(44.4) 14(38.9) 88(36.1)
35-39yrs 2(22.2) 10(27.8) 69(28.3)
>40yrs 1(11.1) 2(5.6) 17(7.0)
BMI Category (kg/m2)
Underweight (<18.5) 0(0.0) 0(0.0) 3(1.3)
Healthy (18.5-24.9) 0(0.0) 8(22.2) 100(43.5)
Overweight (25.0-29.9) 2(22.2) 12(33.3) 66(28.7)
Obese (≥30.0) 7(77.8) 16(44.4) 61(26.5)
Parity
Nulliparous 5(55.6) 25(69.4) 141(57.6)
Parous 4(44.4) 11(30.6) 104(42.4)
Induction of labour 6(66.7) 21(58.3) 76(31.0)
Mode of delivery
Spontaneous Vaginal Cephalic 2(22.2) 7(19.4) 60(24.6)
Instrumental 7(77.8) 29(80.6) 184(75.4)
Manoeuvres*
McRoberts 0(0.0) 4(11.1) –
McRoberts and Suprapubic pressure 7(77.8) 25(69.4) –
Other 2(22.2) 9(25.0) –
Birthweight (grams) 
<3000 0(0) 0(0) 69(28.2)
3000-3499 0(0) 4(11.1) 73(29.8)
3500-3999 5(55.6) 12(33.3) 76(31.0)
≥4000 4(44.4) 20(55.6) 27(11.0)
Birthweight centile
<10th 0(0) 0(0) 49(20.0)
10-49th 2(22.2) 10(27.8) 102(41.6)
50-89th 4(44.4) 15(41.7) 75(30.6)
≥90th 3(33.3) 11(30.6) 19(7.8)
Note: Values are shown as n(%) unless otherwise stated. Maternal age, body mass index (BMI) and mode of delivery were not 
recorded for one, 15 and one case, respectively. *Categories are not mutually exclusive 
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Infant characteristics
Two-thirds of the infants who received TH in 2019 were female (65.3%; n=47 of 72). In the overall population of births 
in 2016, 51.3% were male and 48.7% female (Table 25). There were two infants who underwent TH from multiple 
births (2.8%). This is slightly lower than the proportion of multiples among all births in 2016 (3.8%).10
Table 25: Sex of infants who underwent therapeutic hypothermia in 2016-2019
TH cases  
N=63  
2016
TH cases  
N=77  
2017
TH cases  
N=69  
2018
TH cases  
N=72  
2019





Male 32(50.8) 48(62.3) 53(76.8) 25(34.7) 158(56.2) 51.3%
Female 31(49.2) 29(37.7) 16(23.2) 47(65.3) 123(43.8) 48.7%
Note: Values are shown as N(%) unless otherwise stated
Gestation at delivery
Figure 3 outlines the gestational age at delivery for infants who underwent TH in 2019 versus all infants born in 
201617. Almost two thirds of infants were born between 40 and 42 completed weeks gestation (61.1%; n=44 of 72). 
Figure 3: Gestational age at delivery (weeks) for infants who underwent therapeutic hypothermia in 2019 






















Gesational age at delivery (weeks)
TH General Population 2016
29ANNUAL REPORT 2019
Birthweight at delivery
The mean birthweight for infants who underwent neonatal TH in 2019 was 3,431 grams (Standard Deviation: 629 
grams). The birth weight ranged from 1,680 grams to 5,380 grams. As outlined in Figure 4, almost a third of infants 
weighed 3,000-3,499 grams (29.2%, n=21). Almost half of infants weighed 3,500 grams or more (47.2%, n=34). A 
small proportion of infants weighed between 1,680 and 2,499 grams (5.6%, n=4) and of these four infants, two had 
an antenatal diagnosis of fetal growth restriction (50.0%; n= 2 of 4).
Figure 4: Distribution of birthweight for infants who underwent therapeutic hypothermia in 2019 versus all 
infants born in 2019
Birthweight Centiles
Gestation Related Optimal Weight (GROW) software and coefficients derived from the multiple regression analysis 
of data on 11,072 births in six maternity units in Dublin, Galway, Limerick and Belfast in 2008-2009, was used 
to produce Figure 520 which illustrates the optimal birthweight and normal range compared to the recorded 
birthweights of infants who underwent neonatal TH in 2019.
The optimal weight and normal range for all gestations are plotted with the actual birthweights of the infants in 
Figure 6. As can also be seen in Table 21, one in six of these infants were below the lower limit of the normal range 
(10th centile).
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Figure 5: Optimal birthweight and normal range compared to actual birthweights for infants who underwent 
therapeutic hypothermia in 2019




















































When examined by birth weight centile category, the distribution of the TH cohort was broadly similar to that 
expected but there was some evidence of poor fetal growth. Almost 20% of the infants (n=49, 17.4%) in 2016-2019 
were below the 10th centile.
Table 26: Birth weight centiles for infants who underwent therapeutic hypothermia in 2016-2019
Centiles
TH cases  
2016  
N=63
TH cases  
2017  
N=77
TH cases  
2018  
N=69
TH cases  
2019  
N=72
TH cases  
2016-2019  
N=281
<3rd 2(3.2) 6(7.8) 4(5.8) 3(4.2) 15(5.3)
3rd to 9th 7(11.1) 11(14.3) 8(11.6) 8(11.1) 34(12.1)
10-49th 27(42.9) 28(36.4) 28(40.6) 29(40.3) 112(39.9)
50-89th 17(27.0) 24(31.2) 24(34.8) 25(34.7) 90(32.0)
≥90th 10(15.9) 8(10.4) 5(7.2) 7(9.7) 30(10.7)
Note: Values are shown as N(%) unless otherwise stated 
Table 27: Birth weight centiles for infants who underwent therapeutic hypothermia in 2016-2019
Centiles
TH cases  
2019  
N=72





Rate ratio  
(95% CI)
P-value
<3rd 3(4.2) 15(5.3) 1.99(1.47-2.63) 2.18(1.54-3.08) <0.001
3rd to 9th 8(11.1) 34(12.1)
10-49th 29(40.3) 112(39.9) 1.14(0.94-1.37) 1.24(0.94-1.64) 0.122
50-89th 25(34.7) 90(32.0) 0.91(0.73-1.12) 1.00(ref.)
≥90th 7(9.7) 30(10.7) 1.22(0.82-1.74) 1.33(0.88-2.02) 0.172
Note: Values are shown as N(%) unless otherwise stated 
Based on the four years of data from 2016-2019, there was significant variation in risk of TH associated with 
birthweight centile (Table 27). Infants with a birthweight in the 50-89th centile range had the lowest risk of TH, at 
0.91 per 1,000 births. The risk was 24% and 33% higher among infants in the 10-49th and >90th birthweight centile 
ranges, respectively, but the risk was doubled for infants with a birthweight under the 10th centile.
Diagnosis of fetal growth restriction (FGR)
Data on diagnosis of FGR were recorded for all 72 infants who underwent TH in 2019 (100%). Five (6.9%) of the 72 
infants in 2019 had a diagnosis of FGR in their medical records (Table 28) and for all five the diagnosis was made in 
the antenatal period (as opposed to diagnosis based on observation at delivery or post-mortem). Of those with an 
antenatal diagnosis of FGR, two had a birthweight below the 10th centile and the remaining three had birthweights 
between the 10th and 49th birthweight centiles. 
As previously illustrated in Table 26, there were 11 infants who underwent therapeutic hypothermia in 2019 born 
with a birth weight below the 10th centile. Only two of these 11 infants had a diagnosis of FGR during the antenatal 
period, at delivery or post-mortem (18.1%; n=2 of 11). 
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No diagnosis documented 60(95.2) 66(89.2) 64(92.8) 67(93.1) 258(92.8)
Diagnosis of fetal growth 
restriction
3(4.8) 8(10.8) 5(7.2) 5(6.9) 20(7.2)
Fetal growth restriction 
suspected antenatally
1 of 3(33.3) 5 of 8(62.5) 3 of 5 (60.0) 5 of 5 (100) 13 of 20(65.0)
Note: Values are shown as N(%) unless otherwise stated. *Missing data for three infants 
Resuscitation 
Neonatal or paediatric support was called prior to the delivery of three quarters of cases (76.1%; n=54 of 71; missing 
data for one infant born before arrival). As outlined in Table 29, a registrar was present at the vast majority of births 
for resuscitation (90.1%; n=64 of 71; data missing for one infant). A Senior House Officer (SHO) was also present at 
the majority of births for resuscitation (78.9%; n=56 of 71). A neonatal nurse was present at 40% of births (n=28 of 
71). A consultant was present for 41% of births for resuscitation (40.8%; n=29 of 71).
Table 29: Medical staff present at the time of birth for the resuscitation of infants who underwent therapeutic 
hypothermia in 2016-2019
TH cases  
2016 
N=61*
TH cases  
2017 
N=77
TH cases  
2018 
N=68**
TH cases  
2019 
N=71**
TH cases  
2016-2019 
N=277
Consultant(Neonatology/Paediatrics) 21(34.4) 27(35.1) 28(41.2) 29(40.8) 105(37.9)
Registrar 56(91.8) 73(94.8) 60(88.2) 64(90.1) 253(91.3)
Senior House Officer 48(78.7) 68(88.3) 63(92.6) 56(78.9) 230(83.0)
Neonatal Nurse 22(36.1) 37(48.1) 36(52.9) 28(39.4) 123(44.4)
Midwife 16(26.2) 17(22.1) 11(16.1) 16(22.5) 60(21.7)
Note: Values are shown as N(%) unless otherwise stated. *Data missing for two infants. **Data missing for one infant. Categories are 
not mutually exclusive. These data should be interpreted with caution as documentation related to grade of those in attendance 
was poorly recorded in maternity notes 
As indicated in Table 30, at one minute after birth over three quarters of infants (82.6%; n= 57 of 69) had an Apgar 
score of between zero and three. At ten minutes, infants with an Apgar score of between zero and three had 
reduced to 31.3% (n=20 of 64). At twenty minutes, only three infants had an Apgar score recorded; all of whom had 
a score of two or lower.
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0 13(18.8) 10(14.3) 4(6.3) 2(12.5) 2(66.7)
1 23(33.3) 7(10.0) 8(12.5) 1(6.3) 0(0)
2 14(20.3) 5(7.1) 4(6.3) 1(6.3) 1(33.3)
3 7(10.1) 10(14.3) 4(6.3) 1(6.3) 0(0)
4 6(8.7) 14(20.0) 8(12.5) 3(18.8) 0(0)
5 1(1.4) 7(10.0) 11(17.2) 1(6.3) 0(0)
6 2(2.9) 6(8.6) 8(12.5) 1(6.3) 0(0)
7 2(2.9) 3(4.3) 9(14.1) 3(18.8) 0(0)
8 0(0) 6(8.6) 5(7.8) 2(12.5) 0(0)
9 1(1.4) 1(1.4) 3(4.7) 1(6.3) 0(0)
10 0(0) 1(1.4) 0(0) 0(0) 0(0)
Note: Values are shown as N(%) unless otherwise stated  
An Apgar chart was completed for 55.6% (n=40) of infants at one minute of life; 55.6% (n=40) of infants at five 
minutes of life; 50.0% (n=36) infants at 10 minutes of life and 18.1% (n=13) infants at 15 minutes of life (Table 31). 










Absent 7(17.5) 6(15.0) 2(5.6) 1(7.7)
<100 17(42.5) 5(12.5) 7(19.4) 1(7.7)
>100 16(40.0) 29(72.5) 27(75.0) 11(84.6)
Respiration effort
Absent 31(77.5) 21(52.5) 13(36.1) 6(46.2)
Slow irregular 7(17.5) 14(35.0) 14(38.9) 3(23.1)
Regular crying 2(5.0) 5(12.5) 9(25.0) 4(30.8)
Muscle tone
Limp 34(85.0) 28(38.9) 22(61.1) 6(46.2)
Some flexion 4(10.0) 9(22.5) 13(36.1) 5(38.5)
Active Movement 2(5.0) 3(7.5) 1(2.8) 2(15.4)
Stimulus catheter
Nil 32(80.0) 26(65.0) 18(50.0) 6(46.2)
Grimace 6(15.0) 8(20.0) 15(41.7) 3(23.1)
Cough/sneeze 2(5.0) 6(15.0) 3(8.3) 4(30.8)
Colour
Nil 29(72.5) 13(32.5) 10(27.8) 2(15.4)
Pink body, blue extremities 9(22.5) 22(55.0) 15(41.7) 8(61.5)
Pink 2(5.0) 5(12.5) 11(30.6) 3(23.1)
Note: Values are shown as N(%) unless otherwise stated  
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In 2019, the majority of infants had positive pressure ventilation (PPV) during resuscitation (91.7%; n=66 of 72) which 
began between zero and nine minutes and was sustained between one and 20 minutes. Spontaneous breathing was 
established by almost half of infants (45.8%; n=33 of 72). Of these infants, the age at which spontaneous breathing 
was sustained was recorded for 21 of the 33 infants (66.3%) and began between 2 and 10 minutes (median 4 
minutes). 
As illustrated in Table 32, two thirds of the 72 infants were intubated (63.9%; n=46) which occurred between 1 and 19 
minutes. One third of infants had chest compressions (38.9%, n=28), which began between 0 and 14 minutes (data 
missing for four infants). FiO
2
 was administered to the majority of infants (88.9%, n=64)
















Positive pressure ventilation - - - 66(91.7) -
Spontaneous breathing established 37(58.7) 37(48.1) 36(52.2) 33(45.8) 143(51.1)
Intubation 32(50.8) 50(64.9) 41(59.4) 46(63.9) 170(60.7)
Chest compressions 19(30.2) 28(36.4) 23(33.3) 28(38.9) 98(35.0)
FiO
2
57(90.5) 72(93.5) 61(89.7) 61(89.7) 254(90.7)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive 

















Adrenaline 9(14.3) 9(11.7) 11(15.9) 13(18.1) 42(14.9)
Saline 21(33.3) 21(27.3) 12(17.4) 17(23.6) 81(28.8)
O negative blood 5(7.9) 8(10.4) 2(2.9) 4(5.6) 19(6.8)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive
One of the key indicators for intrapartum asphyxia is severe metabolic acidosis evident in umbilical cord blood at 
delivery21. A cord blood gas measurement was available for 84.7% of infants (n=61). As outlined in Table 34, two 
thirds of infants had a pH of <7.0 from their arterial blood gas (65.4%, n=34 of 52). The median base excess was 
-11.8 (Range: -4.6 to-24.0) from cord blood gases and was -15.9 (Range: -1.5 to -34.8) from initial infant blood gases.
Lactate was recorded for 31.9% of infants (n=23) from cord blood gases and for 91.7% of infants (n=66) from the
initial infant blood gas.
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Table 34: pH level from cord and initial infant blood gases for infants who underwent therapeutic hypothermia 
in 2019














6.4-6.5 0(0.0) 1(1.9) 0(0.0) 0(0.0) (0.0) 0(0.0)
6.51-6.6 1(1.7) 0(0.0) 0(0.0) 2(5.3) 1(8.3) 6(30.0)
6.61-6.7 1(1.7) 0(0.0) 0(0.0) 2(5.3) 2(16.7) 0(0.0)
6.71-6.8 6(10.3) 8(15.4) 0(0.0) 3(7.9) 3(25.0) 3(15.0)
6.81-6.9 5(8.6) 13(25.0) 1(33.3) 5(13.2) 3(25.0) 2(10.0)
6.91-7.0 4(6.9) 12(23.1) 0(0.0) 12(31.6) 1(8.3) 2(10.0)
7.01-7.1 9(15.5) 8(15.4) 0(0.0) 6(15.8) 1(8.3) 0(0.0)
7.11-7.2 15(25.9) 10(19.2) 0(0.0) 6(15.8) 1(8.3) 3(15.0)
7.21-7.3 15(25.9) 0(0.0) 1(33.3) 2(5.3) 0(0.0) 3(15.0)
7.31-7.4 2(3.4) 0(0.0) 1(33.3) 0(0.0) 0(0.0) 1(5.0)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive
Assessment for Therapeutic Hypothermia
In two-thirds of cases the NNTP Cooling Candidacy Checklist was used when making an assessment for TH (66.7%; 
n=48 of 72). Three quarters of the mothers (68.1%), whose infants underwent TH in 2019, experienced an acute 
perinatal event (Table 35). Almost half of infants experienced variable and/or late fetal heart rate decelerations 
during labour (48.6%; n=35).




>36 completed weeks gestational age 72(100)
Apgar score ≤5 at 10 minutes 43(59.7)
Weight ≥1800 grams 71(98.6)
Continued need for PPV or Intubation at 10 mins 49(68.1)
Did an acute perinatal event occur? 49(68.1)
Variable / late fetal heart rate decelerations 35(48.6)
Prolapsed / ruptured / tight nuchal cord 6(8.3)
Uterine Rupture 1(1.4)
Maternal haemorrhage / placental abruption 8(11.1)
Maternal trauma 0(0)
Other 2(2.8)
Acidosis present in umbilical cord, or any blood sample within 60 minutes of birth 45(62.5)
Base Deficit >16.0 mmol/L in umbilical cord, or any blood sample, within 60 minutes of birth 35(48.6)
Note: Values are shown as N(%) unless otherwise stated 
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The majority of the infants (88.9%, n=64 of 72) had a diagnosis of encephalopathy based on having an altered state 
of consciousness, (lethargy, stupor or coma). Although not a requirement for assessment, a grade of encephalopathy 
was assigned to 32.8% of infants (n=21 of 64). Table 36 illustrates that almost three quarters of infants were graded 
as moderately encephalopathic during assessment for TH (76.2%; n=16).
Table 36: Grade of encephalopathy during assessment for therapeutic hypothermia in 2016-2019
TH cases  
2016  
N=29
TH cases  
2017  
N=40
TH cases  
2018  
N=28
TH cases  
2019  
N=21
Mild 3(10.3) 8(20.0) 2(7.1) 0(0.0)
Moderate 17(58.6) 22(55.0) 17(60.7) 16(76.2)
Severe 9(31.0) 10(25.0) 9(32.1) 5(23.8)
Note: Values are shown as N(%) unless otherwise stated 
Transfer to Tertiary Unit
For reasons of safety and expertise, the provision of Neonatal TH by means of active servo-controlled cooling, is 
limited in Ireland to the four tertiary neonatal intensive centres. In order that infants born outside these centres are 
not delayed in accessing TH within the 6 hour window, TH in Ireland is delivered by way of a continuum of care 
between the referring hospital, transport team and tertiary TH centre. 
Utilising national guidelines and documentation,22 TH by means of passive (or active) cooling is commenced at the 
referring hospital as soon as the criteria for cooling22 have been met. The time the target temperature is reached is 
recorded. TH via passive cooling can then be continued during transport by own hospital teams or in those cases 
transported by the NNTP, utilising active servo-controlled cooling. On arrival at the tertiary centre TH via active 
cooling is either continued from an NNTP transfer or initiated after an own hospital transfer.
Almost two-thirds of the 72 infants who underwent neonatal TH in 2019 were born in a tertiary hospital (n=46, 
63.9%; Table 37). The other 26 infants required transfer to a tertiary unit for TH treatment (36.1%). Of the 281 infants 
who received TH during the four-year period 2016-2019, 60% of the infants were born in a tertiary hospital (n=171 of 
281, 59.8%). During the same period, according to HIPE data, 53% of all the mothers who gave birth in hospital did 
so in a tertiary hospital (n=126,720 of 240,472, 52.7%). Thus, TH was provided to 1.35 infants per 1,000 mothers who 
gave birth in a tertiary hospital (95% CI=1.15-1.57) and 0.97 infants per 1,000 mothers who gave birth in a non-tertiary 
hospital (95% CI=0.79-1.17), a 40% difference (Risk ratio=1.40, 95% CI=1.10-1.77, p-value=0.006).
Of the 26 infants who required transfer to a tertiary unit for TH treatment in 2019, a decision to redirect care for one 
infant was taken by the team before transport. The majority of 25 infants were transported by the NNTP (84.0%; 
n=21 of 25) with the remaining four (16.0%) infants being transported by the referring hospital’s team.
Table 37: Transfer of infants to a tertiary unit for therapeutic hypothermia treatment in 2019
TH cases  
2019  
N=72
Inborn at tertiary unit 46(63.9)
Out-born requiring transfer* 26(36.1)
Transferred by the NNTP 21 of 25(84.0)
Transferred by referring hospital’s team 4 of 25(16.0)
Note: Values are shown as N(%) unless otherwise stated. *For one of the 26 infants requiring transfer a decision to redirect care 
was taken by the team before transport
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For the majority of infants who required transfer, a referral call was made to the tertiary cooling centre within two 
hours of birth (80.0%, n=20 of 25; missing data for one infants). A call was made between two and three hours for 
20.0% of infants requiring transport (n=5 of 25; missing data for one infant). 
A decision to redirect care for one infant was taken by the team before transport. All 25 infants who were transferred 
to a tertiary centre were initially passively cooled. Passive cooling was initiated within the first hour of birth for over 
half of infants (54.1%; n=13 of 24; missing data for one infant). All 25 infants who were transferred to a tertiary centre, 
were commenced on TH at the referring hospital within six hours of birth, by means of passive cooling (16.0% ;4 
of 25) and/or active cooling (84.0%; 21 of 25). TH was continued during transport in all cases where infants were 
transferred to a tertiary centre (100%; n= 25). All infants transferred by the NNTP were changed from passive to 
active cooling for transport either before or on departure from the referral hospital (100%; n=21 of 21).
As illustrated in Figure 7, three-quarters of the infants transferred had a core temperature within the target range of 
33°C to 34°C on departure from the referring hospital (76.0%, n=19 of 25). One-quarter of infants (20.0%; n=5 of 25) 
had a core temperature ranging from 34.1°C to 37.7°C. One infant had a core temperature below 33°C.
Figure 7: Temperature (°C) of infant by age (mins) on departure from referring hospital 
Over three-quarters of the 25 infants transferred for neonatal TH treatment required respiratory support (80.0%; 
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Table 38: Management during transfer of infants for therapeutic hypothermia in 2019
NNTP
N=21
Own Hospital Team 
N=4
Respiratory support 18(85.7) 2(50.0)
Ventilation 15 of 18(83.3) 1 of 2 (50.0)





IV access 21(100) 4(100)
Peripheral 21 of 21(100) 4 of 4(100)
Umbilical 17 of 21(81.0) 1 of 4(25.0)
Other 1 of 21(4.8) 0(0)
Note: Values are shown as N(%) unless otherwise stated. For one of the 26 infants requiring transfer a decision to redirect care 
was taken by the team before transport 
Eighty eight percent of the infants requiring transfer to a tertiary unit for TH treatment were admitted more than six 
hours after birth (88.0%; n=22 of 25). One third (32.0%; n=8 of 25) of the infants requiring transfer to a tertiary unit 
for neonatal TH treatment were admitted nine or more hours after birth.
As illustrated in Figure 8, the majority of infants had a core temperature within the target range of 33°C to 34°C 
(88.0%, n=22 of 25) on admission to a tertiary unit. The remaining 12.0% (n=3) had a core temperature ranging from 
34.2°C to 34.9°C when they were admitted to the tertiary unit after six hours of birth. 
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Initiating Treatment 
In line with practice guidelines, TH should be initiated within six hours of birth and should be continued for 72 
hours. The optimum core temperature of 33°C to 34°C is targeted over this 72-hour period. Core temperature was 
recorded for the first twelve hours of birth, or until the initiation of the 72-hour treatment clock. Of the 72 infants, 
half of infants (54.2%; n=39 of 72) were reported to have achieved optimum core temperature within three hours 
of birth. As illustrated in Figure 9 and 10, infants born in a tertiary hospital reached optimum core temperature 
sooner than infants that were outborn requiring transfer. These figures further illustrate that the vast majority of all 
infants, both inborn and outborn, achieved optimum core temperature within six hours of birth (90.3%; n=65 of 72). 
Optimum core temperature was achieved for the remaining 7 infants (9.7%) between 7 and 9 hours of birth. 
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Figure 10: Infant core temperature for the first twelve hours of life for infants born in a regional hospital
The 72-hour treatment clock should begin when the infant reaches the targeted 33-34°C rectal temperature. 
As illustrated in Figure 11, almost two thirds of infants (60.3%; n=41 of 68: data missing for 4 infants) began TH at the 
optimum core temperature of 33°C to 34°C. 
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As outlined in Table 39, almost all infants admitted for neonatal therapeutic hypothermia received sedation on 
Day 1 (95.8%; n=69 of 72), Day 2 (88.9%; n=64 of 72) and Day 3 (80.6%; n=58 of 72) of treatment. All infants were 
administered antibiotics on Day 1 (100%; n=72). The vast majority of infants were administered antibiotics on Day 2 
of treatment (80.6%; n=58 of 72), with almost half receiving antibiotics on Day 3 (45.8%; n=33 of 72). Twelve infants 
required blood products on Day 1 of treatment (16.7%) of which the majority had fresh frozen plasma administered 
(91.7%; n= 11 of 12) and over half who had fibrinogen administered (58.3%; n=7 of 12).
Table 39: Drugs and Volume Replacement Day 1, 2 & 3 in 2019
Day 1 Day 2 Day 3
Sedation 69(95.8) 64(88.9) 58(80.6)
Antibiotics 72(100) 58(80.6) 33(45.8)
Anticonvulsants 28(38.9) 20(27.8) 16(22.2)
Inotropes 18(25.0) 13(18.1) 8(11.1)
Blood products 12(16.7) 2(2.8) 4(5.6)
Volume replacement (normal saline) 18(25.0) 9(12.5) 4(5.6)
Other 20(27.8) 8(11.1) 5(6.9)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive 
One third of the infants who received TH in 2019 had an echocardiogram during their hospital admission (34.7%; 
n=25). All infants had microbiology bloods undertaken (100%; see Table 40). Four of the 72 infants had genetic 
bloods undertaken (5.6%).








Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive 
Over the course of treatment, the median fluid input in milligrams per kg was 48.0 (Range 26-107) on Day 1, 50.0 
(Range 15-71) on Day 2 and 50.0 (Range 34-94) on Day 3. The lowest blood sugar level reported was between 0 
and 3 for a third of infants on Day 1 (38.9%; n=28), Day 2 (30.6%, n=22) and Day 3 (31.9%; n=23). Sodium levels were 
131 or lower for two thirds of infants on Day 1 (65.3%; n=47), over half of infants on Day 2 (56.9%, n=41) and 43.1% 
of infants on Day 3 (n=31).
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Table 41: Laboratory Parameters Day 1, 2 & 3 in 2019*
Day 1 Day 2 Day 3
Coagulation 23(31.9) 9(9.7) 1(1.4)
Blood sugars 
0-3 28(38.9) 22(30.6) 23(31.9)
4-7 37(51.4) 38(52.8) 32(44.4)
≥8 5(6.9) 3(4.2) 3(4.2)
Not documented 2(2.8) 9(12.5) 14(19.4)
Sodium 
≤131 47(65.3) 41(56.9) 31(43.1)
132-136 18(25.0) 16(22.2) 18(25.0)
≥137 6(8.3) 6(8.3) 8(11.1)
Not documented 1(1.4) 9(12.5) 15(20.8)
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive. *Data for laboratory tests which 
may have been undertaken during assessment for TH were not recorded and therefore are not presented here 
In relation to neuroimaging, 73.6% (n=53) of infants had a cranial ultrasound (Table 42) that occurred between Day 
1 and Day 8 of life. Of the 53 cranial ultrasounds undertaken, 13 (24.5%) were reported as abnormal and five were 
reported to have increased echogenicity (9.4%). 







Day 4 or later
N=72
Cranial ultrasound* 19(26.4) 19(26.4) 7(9.7) 6(8.3)
Note: Values are shown as N(%) unless otherwise stated. *Missing day of investigation for two infants 
SARNAT Scoring
A diagnosis of encephalopathy, consisting of an altered state of consciousness (lethargy, stupor or coma) was 
only assigned to 65.3% (n=47 of 72) of infants who had a SARNAT completed on Day 1, for 48.4% (n=31 of 64) on 
Day 2 and 49.1% (n=29 of 59) of infants on Day 3. As outlined in Table 44, over a third were graded as severely 
encephalopathic on Day 1 (40.4%; n=19 of 44), Day 2 (38.7%; 12 of 31) and a quarter on Day 3 (24.1%; n=7 of 29) 
of treatment. Infants were assigned a SARNAT23 score based on clinical behaviour on Day 1, Day 2 and Day 3 of 
treatment (Table 43).
Table 43: SARNAT Scoring on Treatment Day 1, 2 & 3 in 2019
Day 1  
N=72 
Day 2  
N=64
Day 3  
N=59
Level of consciousness
Hyperalert 10(13.9) 5(7.8) 4(6.8)
Lethargic or obtunded 33(45.8) 18(28.1) 23(39.0)
Stupor or Coma 13(18.1) 10(15.6) 3(5.1)
Normal 7(9.7) 12(18.8) 11(18.6)
Undocumented 9(12.5) 19(29.7) 18(30.5)
Activity
Normal 16(22.2) 13(20.3) 14(23.7)
Decreased 31(43.1) 23(35.9) 25(42.4)
Absent 14(19.4) 8(12.5) 3(5.1)
Undocumented 9(12.5) 20(31.3) 17(28.8)
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Neuromuscular Control
Muscle tone Normal 12(16.7) 3(4.7) 10(17.0)
Mild hypotonia 30(41.7) 15(23.4) 14(23.7)
Flaccid 15(20.8) 10(15.6) 5(8.5)
Undocumented 15(20.8) 33(51.6) 30(50.8)
Posture Mild distal flexion 12(16.7) 5(7.8) 8(13.6)
Strong distal flexion 11(15.3) 2(3.1) 5(8.5)
Intermittent decerebration 10(13.9) 7(10.9) 2(3.4)
Normal 12(16.7) 6(9.4) 4(6.8)
Undocumented 27(37.5) 44(68.8) 40(67.8)
Stretch reflexes Overactive 5(6.9) 4(6.3) 7(11.9)
Decreased or absent 15(20.8) 7(10.9) 3(5.1)
Normal 15(20.8) 6(8.3) 7(11.9)
Undocumented 37(51.4) 46(63.9) 40(67.8)
Deferred 0(0.0) 1(1.6) 2(3.4)
Complex Reflexes
Suck Weak 15(20.8) 10(15.6) 8(13.6)
Weak or absent 12(16.7) 3(4.7) 9(15.3)
Absent 13(18.1) 8(12.5) 4(6.8)
Normal 10(13.9) 5(7.8) 8(13.6)
Undocumented 20(27.8) 38(59.4) 30(50.8)
Deferred 2(2.8) 0(0.0) 0(0.0)
Moro Strong; low threshold 2(2.8) 1(1.6) 0(0.0
Weak; incomplete high threshold 4(5.6) 1(1.6) 2(3.4)
Absent 6(8.3) 1(1.6) 1(1.7)
Normal 4(5.6) 1(1.6) 4(5.1)
Undocumented 49(68.1) 55(85.9) 49(83.1)
Deferred 7(9.7) 5(7.8) 4(6.8)
Tonic Neck Slight 2(2.8) 0(0.0 0(0.0)
Strong 3(4.2) 0(0.0) 0(0.0)
Absent 0(0.0) 0(0.0) 1(1.7)
Normal 2(2.8) 0(0.0) 1(1.7)
Undocumented 64(88.9) 62(96.9) 55(93.2)
Deferred 1(1.4) 2(3.1) 2(3.4)
Autonomic Function
Pupils Dilated 1(1.4) 1(1.6) 0(0.0)
Constricted 18(25.0) 8(12.5) 10(16.9)
Variable; often unequal, poor light 
reflex, fixed, dilated 
8(11.1) 4(6.3) 3(5.1)
Normal 17(23.6) 9(14.1) 8(13.6)
Undocumented 28(38.9) 42(65.6) 38(64.4)
Heart rate Tachycardia 5(6.9) 1(1.6) 2(3.4)
Bradycardia 10(13.9) 11(17.2) 6(10.2)
Variable 2(2.8) 2(3.1) 1(1.7)
Normal 45(62.5) 43(67.2) 44(74.6)
Undocumented 10(13.9) 7(10.9) 6(10.2)
Respiratory rate Regular 19(26.4) 22(34.4) 22(37.3)
Periodic breathing 21(29.2) 20(31.3) 16(27.1)
Aponea 21(29.2) 14(21.9) 9(15.3)
Normal 7(9.7) 5(7.8) 9(15.3)
Not documented 4(5.6) 3(4.7) 3(5.1)
Seizures None 41(56.9) 42(65.6) 42(71.2)
Common; focal or multifocal 20(27.8) 9(14.1) 6(10.2)
Uncommon (excluding decerebration) 5(6.9) 7(10.9) 2(3.4)
Normal 4(5.6) 4(6.3) 6(10.2)
Undocumented 2(2.8) 2(3.1) 3(5.1)
Note: Values are shown as N(%) unless otherwise stated 
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Mild 10(21.3) 5(16.1) 4(13.8)
Moderate 18(38.3) 14(45.2) 18(62.1)
Severe 19(40.4) 12(38.7) 7(24.1)
Note: Values are shown as N(%) unless otherwise stated  
Over the course of the 72 hours of treatment, amplitude-integrated electroencephalography (aEEG) interpretation 
was documented for almost two thirds of cases on Day 1 (61.1%; n=44), half of cases on Day 2 (48.6%; n-35) and 
41.7% of cases on Day 3 (n=30). Electrical seizures were identified in 21 of the 72 infants (29.2%) on Day 1, 11 of the 
infants (15.3%) on Day 2 and three of all 72 infants (4.2%) on Day 3 (Table 45). 
Table 45: aEEG interpretation on Treatment Day 1, 2 & 3 in 2019
Day 1  
N=72
Day 2  
N=72
Day 3  
N=72
Background activity 44(61.1) 35(48.6) 30(41.7)
Normal 21 of 44(47.7) 15 of 35(42.9) 16 of 30(53.3)
Abnormal 8 of 44(18.2) 4 of 35(11.4) 1 of 30(3.3)
Moderately abnormal 6 of 44 (13.6) 5 of 35(14.3) 2 of 30(6.7)
Severely abnormal 2 of 44(4.5) 3 of 35(8.6) 1 of 30(3.3)
Not documented 35(48.6) 45(62.5) 52(72.2)
Sleep wake cycle
Present 8 of 44(18.2) 8 of 35(22.9) 14 of 30(46.7)
Absent 6 of 44(13.6) 7 of 35(20.0) 4 of 30(13.3)
Not documented 30 of 44(68.2) 20 of 35(57.1) 12(40.0)
Electrical seizures 21(29.2) 11(15.3) 3(4.2)
Rewarming
Of the 72 infants who underwent TH treatment, 13 infants (18.1%) did not complete 72 hours of TH in 2019. As outlined 
in Table 46, two-thirds of these infants had their care redirected (66.7%; n=8 of 12; missing data for one infant). 
Table 46: Indications to cease TH intervention in infants who underwent TH in 2016-2019 before 72 hours 
completed therapy
TH cases  
N=4  
2016
TH cases  
N=9  
2017
TH cases  
N=8*  
2018
TH cases  
N=12*  
2019
TH cases  
N=33  
2016-2019
Redirection of care 3(75.0) 7(77.8) 5(62.5) 8(66.7) 23(69.7)
PPHN 1(25.0) 1(11.1) 2(25.0) 3(25.0) 7(21.2)
Sepsis 0(0.0) 1(11.1) 1(12.5) 0(0.0) 2(6.1)
Cooling criteria not met 0(0.0) 0(0.0) 0(0.0) 1(8.3) 1(3.0)
Note: Values are shown as N(%) unless otherwise stated. *Missing data for one infant 
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Excluding the 13 infants whose treatment was ceased, data on rewarming was available for 59 of the infants (100%). 
As outlined in Table 47, the majority of infants were rewarmed within 12 hours (91.5%; n=54 of 59) in 2019. During 
the rewarming period, three of the 59 infants (5.1%) had seizures. Infants were rewarmed over periods of between 
1 and 16 hours. 
Table 47: Duration of rewarming for infants who underwent therapeutic hypothermia in 2016-2019
TH cases  
N=59  
2016
TH cases  
N=66  
2017
TH cases  
N=57  
2018
TH cases  
N=59  
2019
TH cases  
N=241  
2016-2019
Up to 12 hours 48(81.4) 50(75.8) 49(86.0) 54(91.5) 197(81.7)
13 – 15 hours 4(6.8) 0(0.0) 1(1.8) 3(35.1) 8(3.3)
16 – 18 hours 7(11.9) 14(21.2) 7(12.3) 2(3.4) 30(12.4)
Greater than 19 hours 0(0.0) 2(3.0) 0(0.0) 0(0.0) 2(0.8)
Note: Values are shown as N(%) unless otherwise stated 
Feeding
Data on the introduction of feeding was recorded for 59 of the 72 infants who underwent TH treatment (81.9%). The 
majority of infants reached full oral requirement (98.3%; n=58 of 59). Ten of the mothers breastfed on introduction 
of feed (16.9%), almost two-thirds of infants were fed with expressed breastmilk (61.0%; n=36 of 59) and 13 were 
fed with formula (22.0%). Data on the day infants who underwent TH had feed introduced was recorded for 58 of 
the 72 infants. As outlined in Table 48, the majority of infants had feed introduced on Day 4 (48.3%; n=28 of 58) or 
Day 5 (22.4%; n=13 of 58). 
Table 48: Age that infants who underwent therapeutic hypothermia in 2016-2019 had feed introduced
TH cases  
N=60  
2016
TH cases  
N=66  
2017
TH cases  
N=63  
2018
TH cases  
N=58  
2019
TH cases  
N=247  
2016-2019
Up to Day 3 6(10.0) 2(3.0) 11(17.5) 7(12.1) 26(10.5)
Day 4 17(28.3) 21(31.8) 33(52.4) 28(48.3) 99(40.1)
Day 5 25(41.7) 28(42.4) 15(23.8) 13(22.4) 81(32.8)
Day 6 8(13.3) 11(16.7) 3(4.8) 7(12.1) 29(11.7)
Day 7+ 4(6.6) 4(6.1) 1(1.6) 3(5.2) 12(4.9)
Note: Values are shown as N(%) unless otherwise stated 
Of these 59, three-quarters of infants were initially fed with a nasogastric tube (78.0%; n=46). Of these, one quarter 
of infants were fed with a nasogastric tube for between 24 hours and 47 hours (25.0%; n= 9 of 36; missing data for 
10 infants). As indicated in Table 49, one infant was discharged home with a nasogastric tube (2.8%).
46 NEONATAL THERAPEUTIC HYPOTHERMIA IN IRELAND
Table 49: Duration of feeding with a nasogastric tube for infants who underwent therapeutic hypothermia in 
2016-2019
TH cases  
N=30  
2016
TH cases  
N=36  
2017
TH cases  
N=34  
2018
TH cases  
N=36  
2019
TH cases  
N=126  
2016-2019
Less than 24 hours 9(30.0) 7(19.4) 8(23.5) 6(16.7) 30(23.8)
24-47 hours 6(20.0) 7(19.4) 3(8.8) 9(25.0) 25(19.8)
48-71 hours 4(13.3) 8(22.2) 1(2.9) 9(25.0) 22(17.5)
Greater than 72 hours 8(26.7) 6(16.7) 21(61.8) 11(30.6) 36(28.6)
Discharged home with a nasogastric tube 3(10.0) 8(22.2) 1(2.9) 1(2.8) 13(10.3)
Note: Values are shown as N(%) unless otherwise stated  
Specific placental conditions 
Of the 72 infants who underwent TH, the placenta was retained and sent for histological analysis in 53 of the 72 
cases (73.6%). Of these, 49 placental examinations were complete (92.5%, n=49 of 53, Table 50). All 49 completed 
reports were made available to the NPEC for inclusion in this report. 
Placental disease categories have been divided into subsections and, while numbers in any one year are small, it will 
assist in understanding the relative contribution of placental conditions. In particular, a severe fetal inflammatory 
response is associated with abnormal neonatal neurologic findings in cases of chorioamnionitis. 
Abnormal placental findings have been classified in line with recommendations from the publication from the 
international consensus meeting of pathology9. These are presented under the following broad categories: maternal 
vascular malperfusion (MVM), fetal vascular malperfusion (FVM), cord pathology, cord pathology with distal disease, 
chorioamnionitis, villitis and other. 
Analysis of placentas from infants treated with TH has shown broadly similar findings to previous years, although 
maternal vascular malperfusion (MVM) shows reduced numbers. MVM, previously classified as uteroplacental 
ischaemia (UPI) is the most common pathology identified in stillbirths and in previous reports on TH placentas for 
2016-18. The submission rate of placentas for TH, at 68.1% (n=49 of 72), may be in part responsible for this.
Two categories previously subsumed into the category of “other” have been listed separately this year. Delayed 
villous maturation renders term infants more susceptible to hypoxia. It may co-exist with and in some cases be 
secondary to impairment in fetoplacental flow (fetal vascular malperfusion, FVM). An important finding is meconium-
associated vascular necrosis (MAVN). This is where meconium passed by the fetus is associated with death of 
smooth muscle cells in the cord or on the chorionic plate, possibly causing vasospasm and thereby worsening 
hypoxia. It would usually be seen in <1/1000 deliveries, and its presence here in 3 of 49 cases deserves scrutiny.
With the increasing use of the Amsterdam criteria9 for placental reporting, the potential for exploration of the 
associations of placental pathology, neonatal course and developmental outcome is enhanced. It is therefore 
critically important that placental submission rates in TH reach if not exceed the excellent rates of >95% achieved 
for stillbirth.
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Table 50: Placental histology findings for infants who underwent neonatal therapeutic hypothermia in 2016-
2019 versus Stillbirths in 2017
TH cases  
N=72  
2016/2017
TH cases  
N=41  
2018






Maternal Vascular Malperfusion (MVM) 19(26.4) 12(29.2) 6(12.2) 81(34.6)
• Low Grade 11(26.8) 2(4.1)
• High Grade 1(2.4) 4(8.2)
Fetal Vascular Malperfusion (FVM) 16(22.2) 7 (17.0) 4(8.2) 60(25.6)
• Low Grade 4(9.7) 1(2.0)
• High Grade 3(7.3) 3(6.1)
Any Cord Pathology 14(19.4) 14 (34.0) 17(34.7) 54(23.1)
• Isolated 9(21.9) 12(24.5)
• Cord Pathology with distal FVM 3 (7.3) 3(6.1)
• Cord Pathology with distal High Grade FVM 2 (4.8) 2(4.1)
Chorioamnionitis 20(27.8) 14(34.1) 10(20.4) 21(9.0)
Chorioamnionitis FIR Stage 2 1(2.4) 0(0.0)
Villitis 3(4.2) 4(9.7) 6(12.2) 10(4.3)
Other Placental Condition 28(38.9) 12(29.2) 13(26.5) 35(15.0)
• Other 6(12.2)
• Delayed Villous Maturation 4(8.2)
• Meconium-associated Vascular Necrosis 3(6.1)
Normal – 3(7.3) 8(16.3) –
Note: Values are shown as N(%) unless otherwise stated. Categories are not mutually exclusive 
Discharge diagnosis and neonatal death
Of the 72 infants who underwent TH treatment, 60 infants had an MRI of the brain undertaken of which 58 infants 
(80.5%) had an MRI report available. One quarter of infants had an MRI on day 5 of life (25.4%; n=15 of 59). One in 
ten infants had an MRI between day 10 and 15 of life (10.2%; n=6 of 59; see Table 51).
The 58 available MRI reports were assessed by adopting the Barkovich scoring system in HIE24. Adopting the 
Barkovich HIE scoring system, almost one third had an abnormal MRI (31.0%; n=18 of 58) compared to 25.4% 
(n=15 of 59) of the infants in 2018 with an abnormal report. The full set of Barkovich HIE scores for infants with an 
abnormal result in 2019 are outlined in Appendix E .











Note: Values are shown as N(%) unless otherwise stated. *Missing data for one infant 
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There was a grade of encephalopathy documented for the majority of the 58 infants who were discharged (89.7%; 
n=52 of 58). The overall grade of encephalopathy assigned to an infant during their admission is the worst grade 
of encephalopathy achieved during admission. When a grade was referenced at discharge, a grade of moderate 
encephalopathy was assigned to over half of cases (57.7%; n=30 of 52; undocumented for 6). One in seven infants 
had a grade of mild on discharge (15.4%, 8 of 52; undocumented for 6).
Table 52: Grade of encephalopathy on discharge in 2016-2019
TH cases  
N=60  
2016
TH cases  
N=68  
2017
TH cases  
N=69  
2018
TH cases  
N=58  
2019
TH cases  
N=255  
2016-2019
HIE – no grade assigned 27(45.0) 29(42.6) 0(0.0) 0(0.0) 56(21.9)
Mild HIE 2(3.3) 3(4.4) 4(5.8) 8(13.8) 17(6.7)
Mild-Moderate HIE 1(1.7) 6(8.8) 4(5.8) 6(10.3) 17(6.7)
Moderate HIE 23(38.3) 18(26.5) 31(44.9) 30(51.7) 102(40.0)
Moderate to Severe HIE 0(0.0) 1(1.5) 3(4.3) 1(1.9) 5(2.0)
Severe HIE 6(10.0) 5(7.4) 15(21.7) 7(13.5) 33(12.9)
HIE not documented 1(1.7) 6(8.8) 12(17.4) 6(10.3) 25(9.8)
Note: Values are shown as N(%) unless otherwise stated 
The survival rate for the infants who underwent TH in 2019 was 79.2%, as 15 of the 72 infants died. Twelve of 
deaths occurred within 7 completed days of birth and were classified as early neonatal deaths (80.0%; n=12 of 15). 
As outlined in Table 53, three deaths occurred after the 7th day and within 28 completed days of birth and were 
classified as late neonatal deaths (20.0%; n=3 of 15). Fourteen of the infants were referred to the coroner (93.3%) 
and 13 infants had an autopsy performed (86.7%). It is important to note that data on the findings of these reports, 
and on the infants’ respective causes of death, were not collected for this report.
Table 53: Perinatal and infant mortality for infants who underwent therapeutic hypothermia in 2016-2019 
TH cases  
N=6  
2016
TH cases  
N=11  
2017
TH cases  
N=7  
2018
TH cases  
N=15  
2019
TH cases  
N=39  
2016-2019
Early neonatal death 0(0.0) 5(45.5) 3(42.9) 12(80.0) 20(51.3)
Late neonatal death 2(33.3) 4(36.4) 3(42.9) 3(20.0) 12(30.8)
Infant death 4(66.7) 2(18.2) 1(14.3) 0(0.0) 7(17.9)
Note: Values are shown as N(%) unless otherwise stated 
As outlined in Table 54, first infant blood lactate level was strongly associated with risk of death among infants 
treated with TH. As expected, infants with a higher blood lactate were at a higher risk of death. The continued need 
for PPV or intubation at 10 mins was also strongly associated with mortality with these infants being 6.9 times more 
at risk. Infants with a base deficit greater than 16.0 mmol/L in umbilical cord, or any blood sample, within 60 minutes 
of birth had 4.9 times higher risk of death compared to the other infants. Similarly, low Apgar score was an indicator 
of mortality risk. Twenty-one percent of the infants with an Apgar score ≤5 at 10 minutes died, which was 4.8 times 
higher than the risk of deaths compared to the other infants. 
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Table 54: Maternal and infant characteristics and mortality risk for infants who underwent therapeutic 










Nulliparous 166 21(12.7) 1.00 (ref.)
Parous 115 18(15.7) 1.24
Mode of delivery
Vaginal delivery 67 10(14.9) 1.00 (ref.)
Instrumental 92 6(6.5) 0.44
CS pre labour 59 14(23.7) 1.59
CS after the onset of labour 63 9(14.3) 0.96
Birthweight centile
<10th 49 6(12.2) 1.57
10-49th 112 23(20.5) 2.64
50-89th 90 7(7.8) 1.00 (ref.)
>90th 30 3(10.0) 1.29
Sex
Male 158 17(10.8) 1.00 (ref.)
Female 123 22(17.9) 1.66
First infant blood lactate
0 to 4 30 1(3.3) 0.76
5 to 14 137 6(4.4) 1.00 (ref.)
15+ 79 20(25.3) 5.78
Undocumented 35 12(34.3) 7.83
Assessment for TH
>36 completed weeks gestational age
Yes 273 39(14.3) 1.00 (ref.)
No 8 0(0.0) 0.00
Apgar score ≤5 at 10 minutes
Yes 135 34(25.2) 7.25
No 144 5(3.5) 1.00 (ref.)
Weight ≥1800 grams
Yes 278 29(14.0) 1.00 (ref.)
No 3 0(0.0) 0.00
Continued need for PPV or  
Intubation at 10 mins
Yes 177 35(19.8) 6.79
No 103 3(2.9) 1.00 (ref.)
Did an acute perinatal event occur?
Yes 172 28(16.3) 1.61
No 109 11(10.1) 1.00 (ref.)
Acidosis present in umbilical cord, or any 
blood sample within 60 minutes of birth
Yes 187 35(18.7) 4.40
No 94 4(4.3) 1.00 (ref.)
Base Deficit >16.0 mmol/L in umbilical 
cord, or any blood sample, within 60 
minutes of birth
Yes 142 31(21.8) 4.95
No 136 6(4.4) 1.00 (ref.)
Diagnosis of encephalopathy during 
assessment for TH
Yes 200 30(15.0) 1.35
No 81 9(11.1) 1.00 (ref.)
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Bayley Scales of Infant and Toddler Development, Third Edition 
(Bayley-III)









Mean (SD) 103.6 (13.4)
Range 70-30
• Above average (≥110) 13 (33.3) 5 (45.5) 1 (16.7)
• Normal range (90-109) 21 (53.8) 6 (54.5) 4 (66.7)
• Mild/Moderate Delay (70-89) 5 (12.9) 0 (0.0) 1 (16.7)
• Extremely Delay (≤69) 0 (0.0) 0 (0.0) 0 (0.0)
Language Composite Score
Mean (SD) 99.1 (16)
Range 74-32
• Above average (≥110) 8 (20.0) 4 (36.4) 1 (16.7)
• Normal range (90-109) 22 (55.0) 5 (45.5) 1 (16.7)
• Mild/Moderate Delay (70-89) 10 (25.0) 2 (18.2) 4 (66.7)
• Extremely Delay (≤69) 0 (0.0) 0 (0.0) 0 (0.0)
Motor Composite Score
Mean (SD) 99.2 (15)
Range 67-139
• Above average (≥110) 9 (22.5) 5 (45.5) 1 (16.7)
• Normal range (90-109) 25 (62.5) 6 (54.5) 4 (66.7)
• Mild/Moderate Delay (70-89) 4 (10.0) 0 (0.0) 1 (16.7)
• Extremely Delay (≤69) 2 (5.0) 0 (0.0) 0 (0.0)
Cognitive Scaled Score**
Mean (SD) 10.9 (2.6)
Range 4-16
• 1SD above (≥13) 10 (27.0) 4 (40.0) 1 (20.0)
• Normal range (8-12) 23 (62.2) 6 (60.0) 4 (80.0)
• 1SD below (≤7) 4 (10.8) 0 (0.0) 0 (0.0)
Receptive Communication (RC) Scaled Score 
Mean (SD) 10.1 (3.1)
Range 4-16
• 1SD above (≥13) 10 (25.0) 4 (36.4) 1 (16.7)
• Normal range (8-12) 25 (62.5) 6 (54.5) 4 (66.7)
• 1SD below (≤7) 5 (12.5) 1 (9.1) 1 (16.7)
Expressive Communication (EC) Scaled Score 
Mean (SD) 9.5 (2.8)
Range 5-15
• 1SD above (≥13) 7 (17.5) 3 (27.3) 1 (16.7)
• Normal range (8-12) 24 (60.0) 6 (54.5) 1 (16.7)
• 1SD below (≤7) 9 (22.5) 2 (18.2) 4 (66.7)
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Fine Motor (FM) Scaled Score 
Mean (SD) 10.8 (3)
Range 4-19
• 1SD above (≥13) 9 (22.5) 6 (54.5) 0 (0.0)
• Normal range (8-12) 27 (67.5) 5 (45.5) 5 (83.3)
• 1SD below (≤7) 4 (10) 0 (0.0) 1 (16.7)
Gross Motor (GM) Scaled Score  
Mean (SD) 9.2 (2.8)
Range 3-17
• 1SD above (≥13) 5 (12.5) 2 (18.2) 1 (16.7)
• Normal range (8-12) 26 (65.0) 8 (72.7) 3 (50.0)
• 1SD below (≤7) 9 (22.5) 1 (9.1) 2 (33.3)
Note: Values are shown as N(%) unless otherwise stated.SD (Standard Deviation). *One missing case. **Three missing cases 
The BSID-III is an individually administered test instrument to assess the developmental functioning of infant to 
toddler and young children between 1 and 24 months. The BSID-III provides standardised outcome composite 
scores for the following domains: cognitive, language and motor development. The scale also provides standardised 
scaled score outcomes for cognitive development, receptive communication, expressive communication, fine motor 
and gross motor development. These scaled scores facilitate the examiner in determining specific delays such as 
expressive communication or gross motor delay while receptive communication and fine motor development could 
be normal. 
As outlined in Table 55, the composite scores and scaled scores are presented for a cohort of 40 children who were 
treated with TH at birth and assessed at 2 years of age using the BSID-lll22. The categories used to represent the 
composite score outcomes across the cohort have been divided into the following: Above Average, Average, Mild/
Moderate Delay and Extremely delayed performance using the Bayley Manual classifications25. These classifications 
demonstrate a broad range of outcomes. Children performing within the mild delayed range would be expected to 
benefit from appropriate and tailored intervention thus improving their outcome over time while children performing 
within the moderate and extremely delayed categories will still face many developmental challenges25.
Scaled scores have also been presented for each domain as these facilitate further breakdown of the results, for 
example, for the language scale we can now look at receptive communication and expressive communication skills 
separately. For the motor scale we can measure fine motor and gross motor separately. These standardised scaled 
scores have been very helpful to clinicians in terms of determining the type of intervention required to address the 
delay. These scaled scores have been broken down to measure High Average (1SD above the mean), Average and 
Delayed (1 SD below the mean) performance in accordance with the Bayley III Manual classification25. 
The Mean scores, Standard Deviations (SD) and Ranges have been calculated for all domains within the group. The 
results show us that 33.3% (n=13) of children scored above average for the Composite Cognitive domain compared 
to 20.0% (n=8) and 22.5% (n=9) respectively for the Composite Language and Motor domains. Average outcome 
scores for the Composite Cognitive and Language domains were measured at 53.8% (n=21) and 55.0% (n=22) 
while average outcomes for the motor composite was 62.5% (n=25). There were two extremely delayed outcomes 
reported for the Composite Motor domain with no reported cases for the Composite Cognitive and Language 
domains. However, 25.0% (n=10) of children demonstrated mild/moderate language delay. When this delay was 
examined further 22.5% (n=9) of children demonstrated performance at 1 SD below the mean for the scaled score 
for Expressive Communication higher than the Receptive Communication domain at 12.5% (n=5). 22.5% (n=9) of 
children demonstrated performance at 1 SD below the mean for the scaled score for Gross Motor development 
higher percentage of delay than for the Fine Motor domain at 10% (n=4). 
Approximately 10% (n=4) of the TH cases that performed the BSID-III scores had abnormal results for the three 
composite scores, cognitive, language and motor. Two of them had a score equal or less than 69 for the motor 
composite score. Almost 70% (n=27) of these cases had a normal score for the three composite scores, cognitive, 
language and motor. Of the eight remaining cases, seven had at least two normal composite scores and one had 
only one normal language composite score. 
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Appendix A. Obstetric Review Tool 
Placental Abruption
Consider risks/aetiology – Previous abruption, 
hypertension, abdominal trauma, smoker, drug misuse.
Uterine Rupture
History of previous caesarean section or other uterine 
surgery. Was oxytocin/prostaglandin used? 
Shoulder Dystocia
Consider risks/aetiology – History of shoulder dystocia, 
BMI, diabetes, macrosomia, failure to progress in labour.
Cord Prolapse 
Consider risks/aetiology – Abnormal presentation, 
unstable lie, ARM?
Maternal Collapse
Consider aetiology – Eclampsia, seizure, myocardial 
infarction, anaesthetic event, amniotic fluid embolus, 
etc.
Fetal Haemorrhage
Consider aetiology placenta previa, vasa previa, 
trauma, placental cause etc. 
Cardiotocograph Monitoring
Consider use and findings – Adequate monitoring, 
appropriate quality of trace, suspicious features, second 
eyes/second review/opinion undertaken, documented 
training of attending medical/midwifery personnel.
Oxytocin
Consider use/misuse; tachyphylaxis, hyper stimulation, 
medical review of inadequate progress, response, etc.
Communication
Assess presence or absence of good practice as 
documented – Second eyes, documentation of 
maternal concerns, concerns escalated appropriately 
to senior midwifery/ senior medical staff, appropriate 
staff: patient ratios. 
Pyrexia/PROM
Consider factors such as – Appropriate review, 
assessment and investigation, care plan, appropriate 
antibiotic therapy, was there an indication for urgent 
delivery, etc.
Failure to Progress
Consider risks/aetiology – Nulliparous or parous 
mother, abnormal presentation, primary or secondary 
FTP, issues with maternal care plan, appropriate 
escalation, appropriate medical response, etc.
Diagnosis of Labour
Consider diagnosis of labour, timing – Did mother 
self-present, time after admission diagnosis of labour 
made, appropriate monitoring, etc.
Induction
Consider documentation – Indication and plan for 
induction, cervical assessment at time of planning, 
indication discussed with consultant if not per 
guideline. Consultant informed if cervix unfavourable 
and kept updated.
Instrumental
Delivery done by appropriate grade of doctor?  
Decision and timing of events documented, 
procedure(s) well documented, consequences of 
repeated attempts considered and understood. 
OBSTETRIC CASE REVIEW TOOL
To investigate the obstetric antecedents 
of an infant requiring therapeutic 
hypothermia intervention. 
When reviewing cases of neonatal 
encephalopathy, the following types of 
data may be helpful to identify learning. 
– MATERNAL DEMOGRAPHICS 
– PREVIOUS PREGNANCY HISTORY
– CURRENT PREGNANCY HISTORY




Document the review team 
including their discipline, 
specialty and grade. 
Not every case that requires 
TH will be covered by this 
review – the above events and 
factors will cover the majority.
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Appendix B. Cooling Candidacy Checklist 
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Appendix B. continued 
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Appendix C. Sarnat Teaching Cards 
Modified Sarnat Staging for Neonatal Encephalopathy 







Lethargic / Obtunded 
 












  Muscle tone 
 
  Posture 
 
























Decreased or Absent 
Complex reflexes 
 
  Suck 
 
  Moro 
 
 




























  Pupils 
 
 
  Heart rate 
 
















Bradycardia      
 





unequal, poor light 















Modified from Sarnat HB, Sarnat MS. Neonatal Encephalopathy Following Fetal Distress.A Clinical and 












 Key parameters to assess level of consciousness: response to stimuli, corneal and gag reflex, motor activity   
 Stimulation technique: Mild stimuli (tactile touch), Moderate stimuli (heel flick), Noxious stimuli (pinch of 
thumbnail/earlobe)      
 
 Hyperalert: respond readily to stimuli, corneal and gag reflexes present, normal motor activity 
 Lethargy: delayed response to stimuli, corneal and gag reflexes present, reduced motor activity 
 Obtunded: delayed, incomplete response to stimuli, corneal and gag reflexes present, markedly reduced motor 
activity 
 Stupor: only respond to strong noxious stimuli, Absent corneal and gag reflexes , no spontaneous motor activity, 
other – shallow ataxic breathing, apnoeic 
 Coma: No response to noxious, vigorous stimulation, absent corneal and gag reflexes, no motor activity 
 
 Posture: Normal posture =  flexion and adduction of all limbs 
 Key deep tendon reflexes: knee, supinator, biceps      
 Mean horizontal papillary diameter: Term neonates: 3.8 mm +/- 0.8mm (SD) 
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Appendix E. Barkovich Scoring in HIE 
Result Watershed (WS) Basal Ganglia/Watershed (BG/W) Basal Ganglia (BG)
Abnormal 1 2 0
Abnormal 5 4 2
Abnormal 2 2 0
Abnormal 0 1 2
Abnormal 0 1 4
Abnormal 0 1 1
Abnormal 0 1 2
Abnormal 4 2 0
Abnormal 1 2 0
Abnormal 2 2 0
Abnormal 1 0 0
Abnormal 2 3 1
Abnormal 5 4 4
Abnormal 2 2 0
Abnormal 0 1 1
Abnormal 3 3 4
Abnormal 0 1 3
Abnormal 4 2 0
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Appendix F. Neonatal Therapeutic Hypothermia Working Group Members
Ms Ann Bowden, Co-ordinator, National Neonatal 
Transport Programme, Rotunda Hospital
Ms Lucille Bradfield, Clinical Nurse Manager, Cork 
University Maternity Hospital
Dr Paul Corcoran, Senior Lecturer in Perinatal 
Epidemiology, National Perinatal Epidemiology 
Centre, National Perinatal Epidemiology Centre 
contributor
Ms Mandy Daly, Representative from a Patient 
Advocacy Group (Director of Advocacy & Policy 
Making, Irish Neonatal Health Alliance (INHA)
Ms Angela Dunne, National Lead Midwife, National 
Clinical Director, National Women and Infants Health 
Programme
Dr Peter Filan, Consultant Neonatologist, Cork 
University Maternity Hospital
Prof Adrienne Foran, Consultant Neonatologist, 
Rotunda Hospital
Prof Richard Greene, Consultant Obstetrician & 
Gynaecologist, Cork University Maternity Hospital, 
Director of the National Perinatal Epidemiology 
Centre
Ms Siobhan Horkan, Programme Manager, National 
Clinical Programmes, Royal College of Physicians
Ms Julie McGinley, Therapeutic Hypothermia Co-
Ordinator, National Programme Paediatrics & 
Neonatology, National Women and Infants Health 
Programme
Ms Cliodhna Grady, Clinical Risk, State Claims Agency
Mr Kilian McGrane, National Director, National 
Women and Infants Health Programme
Dr Peter McKenna, Consultant Obstetrician & 
Gynaecologist, National Clinical Director, National 
Women and Infants Health Programme
Dr Sarah Meaney, Researcher, National Perinatal 
Epidemiology Centre. National Perinatal 
Epidemiology Centre contributor
Prof Eleanor Molloy, Chair of Paediatrics, Trinity 
College Dublin
Dr Eoghan Mooney, Consultant Pathologist, National 
Maternity Hospital 
Prof John Murphy, Lead, Consultant Neonatologist, 
National Maternity Hospital, Director, National Clinical 
Programme in Paediatrics & Neonatology
Dr Veronica O’Donohue, Consultant Radiologist, 
National Maternity Hospital
Dr Cathal O’Keeffe, Head of Clinical Risk, State 
Claims Agency
Dr Indra San Lazaro Campillo, Researcher, National 
Perinatal Epidemiology Centre. National Perinatal 
Epidemiology Centre contributor
Ms Marie Slevin, Clinical Development Psychologist, 
National Maternity Hospital
Dr Deirdre Sweetman, Consultant Neonatologist, 
National Maternity Hospital
Dr Mathew Thomas, Consultant Paediatrician, 
Letterkenny University Hospital 
Prof Martin White, Consultant Neonatologist, 
Coombe Women & Infants University Hospital and 
Our Lady’s Children’s Hospital Crumlin
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Appendix G. Link Representatives from each of the Hospital Sites
Cavan General Hospital;  
Dr Alan Finan/ Ms Evelyn McAdam
Coombe Women & Infants University Hospital;  
Dr Martin White/ Ms Anne O’Sullivan
Cork University Maternity Hospital;  
Dr Peter Filan/ Ms Lucille Bradfield
Kerry General Hospital;  
Dr Pervaiz/ Ms Maudie Creagh
Letterkenny General Hospital;  
Dr Mathew Thomas/ Kathleen Greenough/  
Ms Evelyn Smith
Mayo General Hospital;  
Ms Andrea McGrail
Midland Regional Hospital, Mullingar;  
Ms Geraldine Kavanagh
Midland Regional Hospital, Portlaoise;  
Dr Gallagher/ Ms Yolanda Fennell
National Maternity Hospital;  
Prof John Murphy/ Ms Julie McGinley
Our Lady of Lourdes Hospital, Drogheda;  
Ms Claire Shannon
Portiuncula Hospital;  
Ms Priscilla Neilan/ Ms Deirdre Naughton
Rotunda Hospital;  
Prof Adrienne Foran/ Kathy Conway
Sligo University Hospital;  
Dr Nath Tummuluru/ Ms Madeleine Munnelly
South Tipperary General Hospital;  
Ms Maura Grogan
St. Luke’s General Hospital, Kilkenny;  
Ms Breda O’Dwyer
University Hospital Galway;  
Ms Jean James/ Ms Aine Binchy
University Hospital Limerick;  
Ms Margo Dunworth
University Hospital Waterford;  
Ms Audrey Comerford/ Ms Paula Curtain
Wexford General Hospital;  
Ms Helen McLoughlin
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